image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
deb42789550559f981a032884195522ebc52af753abfd46fd7e5d8a4f801dd4d.png | simple | <table><tr><td></td><td>A MSC</td><td>BM MSC</td><td>COMMON</td></tr><tr><td>INHIBITION OF MMP</td><td>A2M, MMP2, TIMP1, TIMP2</td><td>A2M, MMP2, TIMP2</td><td>A2M, MMP2, TIMP2</td></tr><tr><td>EPITHELIAL ADHERENS JUNCTION</td><td>ACTN1, ACTN4, ACTR2, MYH9, TUBA1C, TUBB, VCL</td><td>ACTN1, ACTN4, ACTR2, ARPC3, IQGAP1, ... | <table><tr><td></td><td>A MSC</td></tr><tr><td>INHIBITION OF MMP</td><td>A2M, MMP2, TIMP1, TIMP2</td></tr><tr><td>EPITHELIAL ADHERENS JUNCTION</td><td>ACTN1, ACTN4, ACTR2, MYH9, TUBA1C, TUBB, VCL</td></tr><tr><td>REMODELING OF EPITHELIAL ADHERENS JUNCTION</td><td>ACTN1, ACTN4, ACTR2, TUBA1C, TUBB, VCL</td></tr><tr><td>... | <table><tr><td>BM MSC</td><td>COMMON</td></tr><tr><td>A2M, MMP2, TIMP2</td><td>A2M, MMP2, TIMP2</td></tr><tr><td>ACTN1, ACTN4, ACTR2, ARPC3, IQGAP1, MYH9, TUBB, VCL</td><td>ACTN1, ACTN4, ACTR2, MYH9, TUBB, VCL</td></tr><tr><td>ACTN1, ACTN4, ACTR2, IQGAP1, NME1, TUBB, VCL</td><td>ACTNI, ACTN4, ACTR2, TUBB, VCL</td></tr>... |
affaba5fe790896184457c4d521c73d789c11d38a2d6dd01f0a087aa47c606c4.png | simple | <table><tr><td>Parameters</td><td>Case report [2]</td><td>Case report [3]</td><td>Our case report</td></tr><tr><td>Age</td><td>76 years</td><td>55 years</td><td>55 years</td></tr><tr><td>Circumcision</td><td>Uncircumcised</td><td>Delayed circumcision</td><td>Infantile circumcision</td></tr><tr><td>Site of stricture</td... | <table><tr><td>Parameters</td><td>Case report [2]</td><td>Case report [3]</td><td>Our case report</td></tr><tr><td>Age</td><td>76 years</td><td>55 years</td><td>55 years</td></tr><tr><td>Circumcision</td><td>Uncircumcised</td><td>Delayed circumcision</td><td>Infantile circumcision</td></tr><tr><td>Site</td><td>Bulba</t... | <table><tr><td>Parameters</td><td>Case report [2]</td><td>Case report [3]</td><td>Our case report</td></tr><tr><td> of stricture</td><td>r urethral stricture</td><td>ulbar urethral stricture</td><td>le and bulbar urethral strictures</td></tr><tr><td>Time to develop malignancy</td><td>4 months</td><td>3 months</td><td>5... |
2c3cdf26b25aafee57e9cd9060e275ce67084d88828269fc3a106348f66e0e5c.png | complex | <table><tr><td> </td><td> </td><td colspan="4">O/E ratios</td></tr><tr><td>hospital</td><td>n. deliveries</td><td>Model 1</td><td>Model 2</td><td>Model 3</td><td>Model 4</td></tr><tr><td>1</td><td>3000</td><td>1.23</td><td>1.22</td><td>1.25</td><td>1.25</td></tr><tr><td>2</td><td>1710</td><td>1.22</td><td>1.22</td><td>... | <table><tr><td></td><td></td><td colspan="4">O/E ratios</td></tr><tr><td>hospital</td><td>n. deliveries</td><td>Model 1</td><td>Model 2</td><td>Model 3</td><td>Model 4</td></tr><tr><td>1</td><td>3000</td><td>1.23</td><td>1.22</td><td>1.25</td><td>1.25</td></tr><tr><td>2</td><td>1710</td><td>1.22</td><td>1.22</td><td>1.... | <table><tr><td></td><td></td><td colspan="4">O/E ratios</td></tr><tr><td>hospital</td><td>n. deliveries</td><td>Model 1</td><td>Model 2</td><td>Model 3</td><td>Model 4</td></tr><tr><td>20</td><td>3456</td><td>1.04</td><td>1.04</td><td>1.05</td><td>1.04</td></tr><tr><td>21</td><td>4837</td><td>0.75</td><td>0.75</td><td>... |
4377c12e18a6de3c83740034481dd7c9e30515d37726c3fa99afac83a3c83794.png | simple | <table><tr><td>Tree</td><td>CT</td><td>CLADHC</td><td>HT</td><td>SbST</td></tr><tr><td>1</td><td><underline>94.8</underline><i> (3.8)</i></td><td>89.1 <i>(3.5)</i></td><td>91.2 <i>(5.6)</i></td><td>89.5 <i>(3.9)</i></td></tr><tr><td>2</td><td>94.0 <i>(3.8)</i></td><td>92.7 <i>(4.1)</i></td><td>87.6 <i>(5.6)</i></td><td... | <table><tr><td>Tree</td><td>CT</td><td>CLADHC</td><td>HT</td><td>SbST</td></tr><tr><td>1</td><td>94.8 (3.8)</td><td>89.1 (3.5)</td><td>91.2 (5.6)</td><td>89.5 (3.9)</td></tr><tr><td>2</td><td>94.0 (3.8)</td><td>92.7 (4.1)</td><td>87.6 (5.6)</td><td>98.5 (5.3)</td></tr><tr><td>3</td><td>79.3 (3.2)</td><td>88.9 (4.7)</td... | <table><tr><td>Average</td><td>89,38 (3.4)</td><td>89.35 (3.7)</td><td>88,28 (4.8)</td><td>89,73 (4.2)</td></tr><tr><td>Std dev.a</td><td>6.71 (0.6)</td><td>5.2 (0.6)</td><td>3.06 (0.5)</td><td>9.81 (0.5)</td></tr></table> |
8de54133b3f6958ba675920f847cc29fa24da293540f5c108ba4560a6e044747.png | complex | <table><tr><td>Area</td><td colspan="4">Bjørndalen</td><td>Sverdrup</td></tr><tr><td>Samples</td><td>Bd1</td><td>Bd2</td><td>Bd3</td><td>Bd4</td><td>Sv1, Sv2</td></tr><tr><td>Type</td><td>Spring water</td><td>Thaw water</td><td>Mix upstream</td><td>Mix downstream</td><td>Mat and sediment</td></tr><tr><td>pH</td><t... | <table><tr><td>Area</td><td>Bjørndalen</td></tr><tr><td>Samples</td><td>Bd1</td></tr><tr><td>Type</td><td>Spring water</td></tr><tr><td>pH</td><td>2.8</td></tr><tr><td>°C (water)</td><td>9</td></tr><tr><td>°C (air)</td><td>6</td></tr><tr><td>Na</td><td>3.1</td></tr><tr><td>K</td><td>1.1</td></tr><tr><td>Zn</td><td>0.3<... | <table><tr><td colspan="3">Bjørndalen</td><td>Sverdrup</td></tr><tr><td>Bd2</td><td>Bd3</td><td>Bd4</td><td>Sv1, Sv2</td></tr><tr><td>Thaw water</td><td>Mix upstream</td><td>Mix downstream</td><td>Mat and sediment</td></tr><tr><td>6.2</td><td>3.5</td><td>3.8</td><td>2.3</td></tr><tr><td>7</td><td>7</td><td>7</td><td>4<... |
82c1a3ce2363446c2cb1542a8becc8af1de965c535b3669039003210e9fc32d6.png | simple | <table><tr><td>Samplelabel</td><td>Addedeuropium(%wt)</td><td>Ca content(at%)</td><td>P content(at%)</td><td>Eu content(at%)</td><td>Ca+Eu/Pratio</td></tr><tr><td>HAP</td><td>0</td><td>6.96</td><td>5.14</td><td>0</td><td>1.35</td></tr><tr><td>HAPEu3%</td><td>3</td><td>9.96</td><td>8.11</td><td>0.16</td><td>1.25</td></t... | <table><tr><td>Samplelabel</td><td>Addedeuropium(%wt)</td><td>Ca content(at%)</td><td>P content(at%)</td><td>Eu content(at%)</td><td>Ca+Eu/Pratio</td></tr><tr><td>HAP</td><td>0</td><td>6.96</td><td>5.14</td><td>0</td><td>1.35</td></tr></table> | <table><tr><td>HAPEu3%</td><td>3</td><td>9.96</td><td>8.11</td><td>0.16</td><td>1.25</td></tr><tr><td>HAPEu5%</td><td>5</td><td>13.67</td><td>10.61</td><td>0.69</td><td>1.35</td></tr><tr><td>HAPEu10%</td><td>10</td><td>14.44</td><td>11.03</td><td>1.43</td><td>1.44</td></tr><tr><td>HAPEu20%</td><td>20</td><td>10.38</td>... |
34a0bedb86823234faa38123560f4b1b849dfefbed2b2f934e42dae4f8691d18.png | simple | <table><tr><td></td><td>Total types</td><td>Total tokens</td><td>TTR</td></tr><tr><td>Proper nouns (<i>Sem1</i>)</td><td>699</td><td>9,516</td><td>0.073</td></tr><tr><td>Basic level count nouns (<i>Sem2</i>)</td><td>2,675</td><td>25,369</td><td>0.105</td></tr><tr><td>Basic level mass nouns (<i>Sem3</i>)</td><td>288</td... | <table><tr><td></td><td>Total types</td><td>Total tokens</td><td>TTR</td></tr></table> | <table><tr><td>Proper nouns (Sem1)</td><td>699</td><td>9,516</td><td>0.073</td></tr><tr><td>Basic level count nouns (Sem2)</td><td>2,675</td><td>25,369</td><td>0.105</td></tr><tr><td>Basic level mass nouns (Sem3)</td><td>288</td><td>2,655</td><td>0.108</td></tr><tr><td>Action words (Sem4a)</td><td>228</td><td>1,419</td... |
88f0c7d2e73b4e9c755fb3f5cc5485085379046628d04896fc6c9cd733da90e9.png | complex | <table><tr><td></td><td>N</td><td>%</td></tr><tr><td>Mean Age = 37.5 (S.D.11)</td><td></td><td></td></tr><tr><td colspan="3">Citizenship</td></tr><tr><td> Greek</td><td>77</td><td>76.2</td></tr><tr><td> Other</td><td>24</td><td>23.8</td></tr><tr><td>Marital status</td><td></td><td></td></tr><tr><td> Unmarried</td><td>5... | <table><tr><td></td><td>N</td><td>%</td></tr><tr><td>Mean Age = 37.5 (S.D.11)</td><td></td><td></td></tr><tr><td colspan="3">Citizenship</td></tr><tr><td>Greek</td><td>77</td><td>76.2</td></tr><tr><td>Other</td><td>24</td><td>23.8</td></tr><tr><td>Marital status</td><td></td><td></td></tr><tr><td>Unmarried</td><td>53</... | <table><tr><td></td><td>N</td><td>%</td></tr><tr><td>rried</td><td>19</td><td>8.8</td></tr><tr><td>Divorced</td><td>21</td><td>20.8</td></tr><tr><td>Widow</td><td>8</td><td>7.9</td></tr><tr><td>Children</td><td></td><td></td></tr><tr><td>Yes</td><td>62</td><td>61.4</td></tr><tr><td>No</td><td>39</td><td>38.6</td></tr><... |
61bf3f91bccbb36e8e00e9e3ecca2a3e456f170c63ea258a02ca7d831709190d.png | complex | <table><tr><td>Category</td><td>Clinical attachment level (CAL)</td><td>Probing pocket depth (PD)</td></tr><tr><td>Severe periodontitis</td><td>≥ 2 interdental sites with CAL ≥ 6 mm (not on same tooth) and</td><td>≥ 1 interdental site with PD ≥ 5 mm</td></tr><tr><td>Moderate periodontitis</td><t... | <table><tr><td>Category</td><td>Clinical attachment level (CAL)</td><td>Probing pocket depth (PD)</td></tr></table> | <table><tr><td>Severe periodontitis</td><td>≥ 2 interdental sites with CAL ≥ 6 mm (not on same tooth) and</td><td>≥ 1 interdental site with PD ≥ 5 mm</td></tr><tr><td>Moderate periodontitis</td><td>≥ 2 interdental sites with CAL ≥ 4 mm (not on same tooth) or</td><td>≥ 2 interdental sites with PD ≥ 5 mm (not on same too... |
788892dd2e0af80f58c2510b1df7dc286389822cfc5f11e67fa80f02e868ee27.png | complex | <table><tr><td></td><td colspan="2">Rural(<i>N</i> = 2, 799)</td><td colspan="2">Urban(1, 925)</td></tr><tr><td>Socioeconomic variables</td><td>Women(1333) %</td><td>Men(1466) %</td><td>Women(1 044) %</td><td>Men(881) %</td></tr><tr><td>Mean age in years(95 % CI)</td><td>64.9(64.4, 65.5)</td><td>64.1(63.6, 64.7)</td><t... | <table><tr><td></td><td colspan="2">Rural(N = 2, 799)</td><td colspan="2">Urban(1, 925)</td></tr><tr><td>Socioeconomic variables</td><td>Women(1333) %</td><td>Men(1466) %</td><td>Women(1 044) %</td><td>Men(881) %</td></tr><tr><td>Mean age in years(95 % CI)</td><td>64.9(64.4, 65.5)</td><td>64.1(63.6, 64.7)</td><td>64.7(... | <table><tr><td></td><td colspan="2">Rural(N = 2, 799)</td><td colspan="2">Urban(1, 925)</td></tr><tr><td>Socioeconomic variables</td><td>Women(1333) %</td><td>Men(1466) %</td><td>Women(1 044) %</td><td>Men(881) %</td></tr><tr><td>Socio-economic status</td><td></td><td></td><td></td><td></td></tr><tr><td>Poorest</td><td... |
05db1e935af9de2917932df9e6ba4aa73361602cca84c83bf104de88223ba9ce.png | complex | <table><tr><td></td><td>Type 45°</td><td>Type 60°</td><td>Type 75°</td><td>Type 90°</td><td><i>p-</i>value</td></tr><tr><td rowspan="3">KVPA,°</td><td rowspan="3">5.1 (0.7)</td><td rowspan="3">5.1 (0.9)</td><td rowspan="3">5.1 (0.9)</td><td rowspan="3">4.4 (1.0)</td><td><i>p1</i>* <i>=</i> 0.01... | <table><tr><td></td><td>Type 45°</td><td>Type 60°</td><td>Type 75°</td><td>Type 90°</td><td>p-value</td></tr><tr><td rowspan="3">KVPA,°</td><td rowspan="3">5.1 (0.7)</td><td rowspan="3">5.1 (0.9)</td><td rowspan="3">5.1 (0.9)</td><td rowspan="3">4.4 (1.0)</td><td>p1* = 0.017</td></tr><tr><td>p2* = 0.004</td></tr><tr><t... | <table><tr><td rowspan="2">mMDFA,°</td><td rowspan="2">94.0 (1.2)</td><td rowspan="2">93.3 (2.1)</td><td rowspan="2">94.3 (2.0)</td><td rowspan="2">95.0 (1.6)</td><td>p5* = 0.008</td></tr><tr><td>p6* = 0.001</td></tr><tr><td rowspan="3">HKA,°</td><td rowspan="3">179.8 (2.3)</td><td rowspan="3">179.3 (2.1)</td><td rowsp... |
a0248753afb763ba39ed045836f65b9d6dd3eaecbfe085e46bde155262413826.png | simple | <table><tr><td>Target</td><td>Accession Number</td><td>Forward Primer</td><td>Reverse Primer</td></tr><tr><td>Cyp2a4</td><td>NM_009997</td><td>GGAAGACGAACGGTGCTTTC</td><td>CCCGAAGACGATTGAGCTAATG</td></tr><tr><td>Cyp3a11</td><td>NM_007818</td><td>CGCCTCTCCTTGCTGTCACA</td><td>CTTTGCCTTCTGCCTCAAGT</td></tr><tr><td>Cyp2c37... | <table><tr><td>Target</td><td>Accession Number</td><td>Forward Primer</td><td>Reverse Primer</td></tr></table> | <table><tr><td>Cyp2a4</td><td>NM_009997</td><td>GGAAGACGAACGGTGCTTTC</td><td>CCCGAAGACGATTGAGCTAATG</td></tr><tr><td>Cyp3a11</td><td>NM_007818</td><td>CGCCTCTCCTTGCTGTCACA</td><td>CTTTGCCTTCTGCCTCAAGT</td></tr><tr><td>Cyp2c37</td><td>NM_010001</td><td>ATACTCTATATTTGGGCAGG</td><td>GTTCCTCCACAAGGCAAC</td></tr><tr><td>Cyp... |
5e3aae17c2e0c91e092f78e3af8c65ae65be516ef58958b721cb3e744940bc95.png | complex | <table><tr><td rowspan="3">Surveillance site</td><td colspan="8">Diarrhoea cases</td><td rowspan="2">Total</td></tr><tr><td colspan="2">Non-diarrhoea cases</td><td colspan="2">Rotavirusdiarrhoea</td><td colspan="2">Cholera</td><td colspan="2">Non-rotavirus and non-cholera diarrhoea</td></tr><tr><td>No.</td><td>%</td><t... | <table><tr><td rowspan="3">Surveillance site</td><td colspan="8">Diarrhoea cases</td><td rowspan="2">Total</td></tr><tr><td colspan="2">Non-diarrhoea cases</td><td colspan="2">Rotavirusdiarrhoea</td><td colspan="2">Cholera</td><td colspan="2">Non-rotavirus and non-cholera diarrhoea</td></tr><tr><td>No.</td><td>%</td><t... | <table><tr><td>rganj</td><td></td><td>63.7</td><td>1</td><td>2.1</td><td>7</td><td>5</td><td>5</td><td>7</td><td>6</td></tr><tr><td>Mathbaria</td><td>163</td><td>60.0</td><td>38</td><td>14.0</td><td>23</td><td>8.5</td><td>48</td><td>17.7</td><td>272</td></tr><tr><td>Total</td><td>326</td><td>61.7</td><td>69</td><td>13.... |
032e50712b93da2bad1d1200be9de169adc627258b7ebb2b119363cfdf05751d.png | simple | <table><tr><td>Variables</td><td>OR</td><td>95% CI</td><td>p-value</td></tr><tr><td>Age: ≤28</td><td>1.277</td><td>0.489-3.333</td><td>0.617</td></tr><tr><td>Gender: male</td><td>1.237</td><td>0.366-4.183</td><td>0.732</td></tr><tr><td>Smoking: no</td><td>2.717</td><td>1.017-7.257</td><td>0.046</td></tr><tr><td>L... | <table><tr><td>Variables</td><td>OR</td><td>95% CI</td><td>p-value</td></tr><tr><td>Age: ≤28</td><td>1.277</td><td>0.489-3.333</td><td>0.617</td></tr><tr><td>Gender: male</td><td>1.237</td><td>0.366-4.183</td><td>0.732</td></tr></table> | <table><tr><td>Smoking: no</td><td>2.717</td><td>1.017-7.257</td><td>0.046</td></tr><tr><td>Lesion: top</td><td>1.531</td><td>0.484-4.844</td><td>0.469</td></tr><tr><td>Comorbidities: yes</td><td>3.413</td><td>1.236-9.433</td><td>0.018</td></tr><tr><td>ISP: yes</td><td>0.862</td><td>0.3615-2.364</td><td>0.773</td></tr>... |
c24a69436bd584c92ae274c79da75d88f81294cc4d2475872ee05225e5101ebc.png | simple | <table><tr><td></td><td>12-pNCA</td><td>2PE</td><td>PROP</td><td>11PA</td><td>2A5C</td><td>MDOB</td><td>ALL</td></tr><tr><td>Correlation</td><td>0.32 (0.06)</td><td>0.27 (0.11)</td><td>0.06 (0.71)</td><td>0.12 (0.48)</td><td>0.20 (0.24)</td><td>0.36 (0.04)</td><td>0.22(10<sup>-3</sup>)</td></tr></table> | <table><tr><td></td><td>12-pNCA</td><td>2PE</td><td>PROP</td><td>11PA</td><td>2A5C</td><td>MDOB</td><td>ALL</td></tr></table> | <table><tr><td>Correlation</td><td>0.32 (0.06)</td><td>0.27 (0.11)</td><td>0.06 (0.71)</td><td>0.12 (0.48)</td><td>0.20 (0.24)</td><td>0.36 (0.04)</td><td>0.22(10-3)</td></tr></table> |
996e57ad46b2569afe574be932d92f6f6ecc03c2073ebc45a65bf8fe618df5d0.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">Total</td><td colspan="2">Male sex</td><td colspan="2">Female sex</td></tr><tr><td>Normouricemia (<i>n</i> = 1749)</td><td>Hyperuricemia (<i>n</i> = 393)</td><td>Normouricemia (<i>n</i> = 954)</td><td>Hyperuricemia (<i>n</i> = 238)</td><td>Normouricemia (<i>n</i> = 795)</... | <table><tr><td rowspan="2"></td><td colspan="2">Total</td><td colspan="2">Male sex</td><td colspan="2">Female sex</td></tr><tr><td>Normouricemia (n = 1749)</td><td>Hyperuricemia (n = 393)</td><td>Normouricemia (n = 954)</td><td>Hyperuricemia (n = 238)</td><td>Normouricemia (n = 795)</td><td>Hyperuricemia (n = 155)</td>... | <table><tr><td>-year</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>CAD</td><td>25</td><td>8</td><td>16</td><td>5</td><td>9</td><td>3</td></tr><tr><td>Congestive heart failure</td><td>6</td><td>3</td><td>3</td><td>2</td><td>3</td><td>1</td></tr><tr><td>Stroke</td><td>11</td><td>2</td><td>6</td><... |
0a7ed016fa9717cbda826640e9047c02793106479f348645a87d3c5f1e2d66b2.png | complex | <table><tr><td></td><td>ASD (<i>n</i> = 24)</td><td>Controls (<i>n</i> = 18)</td><td>Statistics</td></tr><tr><td>Age</td><td>40.54 ± 10.279</td><td>37.17 ± 10.983</td><td><i>p</i> = 0.313</td></tr><tr><td>Intelligence quotient</td><td>114.29 ± 15.213</td><td>113.00 ± 13.920</td><td><i>p</i> = 0.779<... | <table><tr><td></td><td>ASD (n = 24)</td><td>Controls (n = 18)</td><td>Statistics</td></tr><tr><td>Age</td><td>40.54 ± 10.279</td><td>37.17 ± 10.983</td><td>p = 0.313</td></tr><tr><td>Intelligence quotient</td><td>114.29 ± 15.213</td><td>113.00 ± 13.920</td><td>p = 0.779</td></tr><tr><td>Gender</td><td>12 m:12 f</td><t... | <table><tr><td rowspan="3">atric medication (in the last 3 months)</td><td>, 1</td><td> 0</td><td rowspan="3"></td></tr><tr><td>AD + NL, 5</td><td>AD + NL, 0</td></tr><tr><td>AD + MPH, 1</td><td>AD + MPH, 0</td></tr></table> |
c910cdc766d3d76bd21d924006ac5561f193c486f0e5b2c292da0586236eed29.png | simple | <table><tr><td>Cytological diagnosis</td><td>Frequency (n)</td><td>Percentage (%)</td></tr><tr><td>Chronic granulomatous inflammation</td><td>20</td><td>27.0%</td></tr><tr><td>Chronic sialadenitis</td><td>25</td><td>33.7%</td></tr><tr><td>Acute on chronic sialdenitis</td><td>22</td><td>29.7%</td></tr><tr><td>Benign cys... | <table><tr><td>Cytological diagnosis</td><td>Frequency (n)</td><td>Percentage (%)</td></tr><tr><td>Chronic granulomatous inflammation</td><td>20</td><td>27.0%</td></tr><tr><td>Chronic sialadenitis</td><td>25</td><td>33.7%</td></tr><tr><td>Acute on chronic sialdenitis</td><td>22</td><td>29.7%</td></tr></table> | <table><tr><td>Benign cystic lesion</td><td>7</td><td>9.4%</td></tr><tr><td>Total</td><td>74</td><td>39.5%</td></tr></table> |
d2b00a7885ed32740e52b3bd095474678d628fe54f7e0cc745c5b513d358a1fd.png | simple | <table><tr><td>Plasmid</td><td>Properties</td><td>Source/Reference</td></tr><tr><td>pRS316</td><td>Yeast centromeric plasmid. <i>URA3</i> marker.</td><td>[52]</td></tr><tr><td>pRS316[P<sub>PHO84</sub>-GFP-T<sub>PHO84</sub>] (pRUL1336)</td><td>pRS316 containing the <i>PHO84</i> promoter (600 bp), GFP and the <i>PHO84</i... | <table><tr><td>Plasmid</td><td>Properties</td><td>Source/Reference</td></tr><tr><td>pRS316</td><td>Yeast centromeric plasmid. URA3 marker.</td><td>[52]</td></tr><tr><td>pRS316[PPHO84-GFP-TPHO84] (pRUL1336)</td><td>pRS316 containing the PHO84 promoter (600 bp), GFP and the PHO84 terminator (436 bp)</td><td>This study</t... | <table><tr><td>Plasmid</td><td>Properties</td><td>Source/Reference</td></tr><tr><td>pRS305</td><td>Yeast integration plasmid. LEU2 marker.</td><td>[52]</td></tr><tr><td>pRS305[PPHO84-GFP-TPHO84] (pRUL1359)</td><td>pRS305 containing the PHO84 promoter (600 bp), GFP and the PHO84 terminator (436 bp)</td><td>This study</t... |
19f0a829f8912952abc185954f07da79595b5973060e7fb359eaad5269a62ff8.png | complex | <table><tr><td colspan="9">Down-regulated genes</td></tr><tr><td></td><td>mst<sup>1ts</sup></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Gene</td><td>Log2 change</td><td>p-value</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>SPAC1039.02</td><td>-2.66</td><td>0.... | <table><tr><td colspan="7">Down-regulated genes</td></tr><tr><td></td><td>mst1ts</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Gene</td><td>Log2 change</td><td>p-value</td><td></td><td></td><td></td><td></td></tr><tr><td>SPAC1039.02</td><td>-2.66</td><td>0.000635869</td><td></td><td></td><td></td><td></... | <table><tr><td colspan="2">Down-regulated genes</td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td colspan="2">Up-regulated genes</td></tr><tr><td>mst1ts</td><td></td></tr><tr><td>Log2 change</td><td>p-value</td></tr><t... |
6b76373d886ffd28d751c37a78fe08fbbb438d4c221c7664fe429ac58b9bb3ba.png | simple | <table><tr><td></td><td><i>N</i></td><td>%</td></tr><tr><td>Clinic location</td><td></td><td></td></tr><tr><td> Rural</td><td>18</td><td>60</td></tr><tr><td> Urban</td><td>5</td><td>17</td></tr><tr><td> Peri-urban</td><td>7</td><td>23</td></tr><tr><td>Clinic type</td><td></td><td></td></tr><tr><td> Quaternary/tertiary<... | <table><tr><td></td><td>N</td><td>%</td></tr><tr><td>Clinic location</td><td></td><td></td></tr></table> | <table><tr><td>Rural</td><td>18</td><td>60</td></tr><tr><td>Urban</td><td>5</td><td>17</td></tr><tr><td>Peri-urban</td><td>7</td><td>23</td></tr><tr><td>Clinic type</td><td></td><td></td></tr><tr><td>Quaternary/tertiary</td><td>1</td><td>3</td></tr><tr><td>Secondary</td><td>1</td><td>3</td></tr><tr><td>Primary</td><td>... |
1b357d3df36d7125bed00fe4279f1e4de6dedc46cff093eb89fd2a4081df2363.png | simple | <table><tr><td>Exposure</td><td>Study groups</td><td></td><td></td></tr><tr><td>Serum<sup>b</sup></td><td>Infections</td><td>White blood cells</td><td>Lymphocyte subsets</td></tr><tr><td>CB 28+52+101</td><td>4 (3–427)</td><td>4 (3–427)</td><td>4 (3–19)</td></tr><tr><td>CB-153</td><td>60 (23–179)... | <table><tr><td>Exposure</td></tr><tr><td>Serumb</td></tr><tr><td>CB 28+52+101</td></tr><tr><td>CB-153</td></tr><tr><td>Di-ortho PCB</td></tr><tr><td>Mono-ortho PCB TEQ</td></tr><tr><td>p,p'-DDE</td></tr><tr><td>Mother's milk exposurec</td></tr><tr><td>CB 28+52+101</td></tr><tr><td>CB-153</td></tr><tr><td>Di-ortho PCB</... | <table><tr><td>Study groups</td><td></td><td></td></tr><tr><td>Infections</td><td>White blood cells</td><td>Lymphocyte subsets</td></tr><tr><td>4 (3–427)</td><td>4 (3–427)</td><td>4 (3–19)</td></tr><tr><td>60 (23–179)</td><td>57 (23–158)</td><td>59 (23–158)</td></tr><tr><td>131 (44–362)</td><td>127 (44–342)</td><td>129... |
98c1011578002bc1b0b4b555445477896756dab34803dbfd2f76e8b421d1950a.png | simple | <table><tr><td>Variable</td><td>Category</td><td>C<sub>m</sub></td><td>C<sub>c</sub></td><td>C<sub>i</sub></td><td>C<sub>a</sub></td><td>TFR</td></tr><tr><td>Religion</td><td>Catholic</td><td>0.756688</td><td>0.81124</td><td>0.72359</td><td>1.0</td><td>6.8</td></tr><tr><td></td><td>Protestant</td><td>0.688570</td><td>0... | <table><tr><td>Variable</td><td>Category</td><td>Cm</td><td>Cc</td><td>Ci</td><td>Ca</td><td>TFR</td></tr><tr><td>Religion</td><td>Catholic</td><td>0.756688</td><td>0.81124</td><td>0.72359</td><td>1.0</td><td>6.8</td></tr><tr><td></td><td>Protestant</td><td>0.688570</td><td>0.76740</td><td>0.74156</td><td>1.0</td><td>6... | <table><tr><td>Variable</td><td>Category</td><td>Cm</td><td>Cc</td><td>Ci</td><td>Ca</td><td>TFR</td></tr><tr><td>Residence</td><td>Rural</td><td>0.761407</td><td>0.81240</td><td>0.72966</td><td>1.0</td><td>6.9</td></tr><tr><td></td><td>Urban</td><td>0.562910</td><td>0.56882</td><td>0.79239</td><td>1.0</td><td>3.9</td>... |
13d306ca145b950da438fc5c35c7dc0c928a43b1c5054c72293a46c2e9542a25.png | simple | <table><tr><td>Profession</td><td>Round 1</td><td>Round 2</td><td>Round 3</td></tr><tr><td>P-HEMS doctors</td><td>21</td><td>16</td><td>15</td></tr><tr><td>P-HEMS nurses</td><td>14</td><td>12</td><td>12</td></tr><tr><td>EMS nurses</td><td>28</td><td>27</td><td>26</td></tr><tr><td>Dispatch centre operators</td><td>14</t... | <table><tr><td>Profession</td><td>Round 1</td><td>Round 2</td><td>Round 3</td></tr><tr><td>P-HEMS doctors</td><td>21</td><td>16</td><td>15</td></tr><tr><td>P-HEMS nurses</td><td>14</td><td>12</td><td>12</td></tr><tr><td>EMS nurses</td><td>28</td><td>27</td><td>26</td></tr><tr><td>Dispatch centre operators</td><td>14</t... | <table><tr><td>Total respondents</td><td>83</td><td>79</td><td>71</td></tr></table> |
43a616e7a1f36fd5fee5d75cfc4c15e127c4a7dcd45b291ee09b8f4123c6309c.png | simple | <table><tr><td></td><td></td><td>Hierarchical clustering</td><td>CCA</td><td>TribeMCL</td><td>Spectral clustering</td></tr><tr><td>Cluster count</td><td>Significant</td><td>243</td><td>243</td><td>245</td><td>235</td></tr><tr><td></td><td>All</td><td>293</td><td>307</td><td>332</td><td>308</td></tr><tr><td></td><td>Rat... | <table><tr><td></td><td></td><td>Hierarchical clustering</td><td>CCA</td><td>TribeMCL</td><td>Spectral clustering</td></tr><tr><td>Cluster count</td><td>Significant</td><td>243</td><td>243</td><td>245</td><td>235</td></tr><tr><td></td><td>All</td><td>293</td><td>307</td><td>332</td><td>308</td></tr><tr><td></td><td>Rat... | <table><tr><td></td><td></td><td>Hierarchical clustering</td><td>CCA</td><td>TribeMCL</td><td>Spectral clustering</td></tr><tr><td></td><td>Ratio</td><td>0.835</td><td>0.866</td><td>0.889</td><td>0.903</td></tr></table> |
40ede6d239b80006a1046ef017783831a632be6b4e10cf6bd7c55edbe797cc31.png | simple | <table><tr><td>missing rate(%)</td><td>KNN</td><td>SKNN</td><td>EM-SKNN</td><td>MI</td><td>MLE</td></tr><tr><td>10</td><td>0.2171</td><td>0.2247</td><td>0.2239</td><td>0.1573</td><td>0.2112</td></tr><tr><td>20</td><td>0.2233</td><td>0.2223</td><td>0.2175</td><td>0.2171</td><td>0.2602</td></tr><tr><td>30</td><td>0.2422<... | <table><tr><td>missing rate(%)</td><td>KNN</td><td>SKNN</td><td>EM-SKNN</td><td>MI</td><td>MLE</td></tr><tr><td>10</td><td>0.2171</td><td>0.2247</td><td>0.2239</td><td>0.1573</td><td>0.2112</td></tr></table> | <table><tr><td>missing rate(%)</td><td>KNN</td><td>SKNN</td><td>EM-SKNN</td><td>MI</td><td>MLE</td></tr><tr><td>20</td><td>0.2233</td><td>0.2223</td><td>0.2175</td><td>0.2171</td><td>0.2602</td></tr><tr><td>30</td><td>0.2422</td><td>0.2285</td><td>0.2224</td><td>0.2277</td><td>0.2907</td></tr><tr><td>40</td><td>0.2778<... |
3df8330162e4eb55b76a2a26cc0825cf2e223732d63445d52ae053497de8d2de.png | simple | <table><tr><td>Primer name</td><td>Primer sequence (5′–3′)</td></tr><tr><td>Block-E1</td><td>CTACAAATCTTGTTACGCGGTATTA</td></tr><tr><td><i>argX-hisR</i> 5′ intergenic region</td><td>CAGCTCAAGCGCCGGGACTA</td></tr><tr><td><i>argX-hisR</i> centre intergenic region</td><td>TATTACTACCACCGCAGC</td></t... | <table><tr><td>Primer name</td><td>Primer sequence (5′–3′)</td></tr><tr><td>Block-E1</td><td>CTACAAATCTTGTTACGCGGTATTA</td></tr><tr><td>argX-hisR 5′ intergenic region</td><td>CAGCTCAAGCGCCGGGACTA</td></tr><tr><td>ar</td><td>TA</td></tr></table> | <table><tr><td>gX-hisR centre intergenic region</td><td>TTACTACCACCGCAGC</td></tr><tr><td>Block-E2</td><td>TTGTCACAACTTCTAATAA</td></tr><tr><td>Block-E3</td><td>TTTTAGTTCAATTCTTTAAAGTCG</td></tr><tr><td>Block-E4</td><td>AATACTGCTTTTTGAATTTTTAG</td></tr></table> |
b202fa9cc678ccce76b46557928da832d8961da221290c0bae0157e25500c9b8.png | simple | <table><tr><td>Sample</td><td>Average Coverage after 1 s of SP</td><td>Coverage Standard Deviation after 1 s of SP</td><td>AR Coeff.</td><td><i>t</i> (98%) [s]</td></tr><tr><td>CD</td><td>65</td><td>3.0</td><td>1.05</td><td>3.71</td></tr><tr><td>A36</td><td>89</td><td>3.7</td><td>2.18</td><td>1.79</td></tr><tr><td>A72<... | <table><tr><td>Sample</td><td>Average Coverage after 1 s of SP</td><td>Coverage Standard Deviation after 1 s of SP</td><td>AR Coeff.</td><td>t (98%) [s]</td></tr><tr><td>CD</td><td>65</td><td>3.0</td><td>1.05</td><td>3.71</td></tr><tr><td>A36</td><td>89</td><td>3.7</td><td>2.18</td><td>1.79</td></tr><tr><td>A72</td><td... | <table><tr><td>Sample</td><td>Average Coverage after 1 s of SP</td><td>Coverage Standard Deviation after 1 s of SP</td><td>AR Coeff.</td><td>t (98%) [s]</td></tr><tr><td>S1300</td><td>60</td><td>3.3</td><td>0.92</td><td>4.28</td></tr><tr><td>S1400</td><td>73</td><td>2.6</td><td>1.31</td><td>2.98</td></tr></table> |
f3e833afdcd1c4474d3c1c495136492ddf7be3f8359689fc6c4a94d0f4a85300.png | complex | <table><tr><td>Characteristic</td><td colspan="2">All women (<i>n = 543</i>)</td><td colspan="2">Subset (<i>n = 147</i>)</td><td><i>p</i> value</td></tr><tr><td>Variables</td><td><i>n</i></td><td>Mean ± SD</td><td><i>n</i></td><td>Mean ± SD</td><td></td></tr><tr><td>Age (years)</td><td>542</td><td>34.9 ±... | <table><tr><td>Characteristic</td><td colspan="2">All women (n = 543)</td><td colspan="2">Subset (n = 147)</td><td>p value</td></tr><tr><td>Variables</td><td>n</td><td>Mean ± SD</td><td>n</td><td>Mean ± SD</td><td></td></tr><tr><td>Age (years)</td><td>542</td><td>34.9 ± 11.3</td><td>147</td><td>25.5 ± 5.0</td><td><0.00... | <table><tr><td>Marital Status</td><td></td><td></td><td></td><td></td><td><0.001</td></tr><tr><td>Not married</td><td>72</td><td>13.33</td><td>37</td><td>25.17</td><td></td></tr><tr><td>Ever married</td><td>468</td><td>86.67</td><td>110</td><td>74.83</td><td></td></tr><tr><td>Education</td><td></td><td></td><td></td><t... |
f4afc5b25196d5967af07a2a750dbfbc6208017f4b2003dc2c9700409c656f7a.png | simple | <table><tr><td>Year Post Op</td><td>Glenoid Loosening</td><td>Bearing failure</td><td>Infection</td><td>Dislocation</td></tr><tr><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>2</td><td>0</td><td>1</td><td>0</td><td>0</td></tr><tr><td>3</td><td>0</td><td>0</td><td>0</td><td>1</td></tr><tr><td>4</td><td>... | <table><tr><td>Year Post Op</td><td>Glenoid Loosening</td><td>Bearing failure</td><td>Infection</td><td>Dislocation</td></tr><tr><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td></tr></table> | <table><tr><td>2</td><td>0</td><td>1</td><td>0</td><td>0</td></tr><tr><td>3</td><td>0</td><td>0</td><td>0</td><td>1</td></tr><tr><td>4</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Total</td><td>0</td><td>1</td><td>0</td><td>1</td></tr></table> |
a5b2fd70fce589c11b3d55cc88591907e3897dff9451198ae3cbeaa59e062e55.png | simple | <table><tr><td>WHO region</td><td>ILO LABORSTA (farm worker average wage)</td><td>World Bank (average value per agricultural worker)</td><td>ILO (minimum wage)</td><td>US State Department (minimum wage)</td><td>Overall average – maximum of sources<sup>a</sup></td><td>Overall average – minimum of sources<sup... | <table><tr><td>WHO region</td><td>ILO LABORSTA (farm worker average wage)</td><td>World Bank (average value per agricultural worker)</td><td>ILO (minimum wage)</td><td>US State Department (minimum wage)</td><td>Overall average – maximum of sourcesa</td><td>Overall average – minimum of sourcesa</td></tr><tr><td>AMRO</td... | <table><tr><td>WHO region</td><td>ILO LABORSTA (farm worker average wage)</td><td>World Bank (average value per agricultural worker)</td><td>ILO (minimum wage)</td><td>US State Department (minimum wage)</td><td>Overall average – maximum of sourcesa</td><td>Overall average – minimum of sourcesa</td></tr><tr><td>RO</td><... |
ec9a5a92ab97f052859117d4dfc3a9f6bf410e3f0cd7663197defdc32fc1a750.png | simple | <table><tr><td>Subject</td><td>Gender</td><td>Age (yrs)</td><td>Etiology</td><td>Deafness (yrs)</td><td>CI side</td><td>CI experience (mos)</td><td>CVC (Ph%)</td><td>Implant</td></tr><tr><td>S1</td><td>Male</td><td>60</td><td>Familial</td><td>46</td><td>Left</td><td>160</td><td>93</td><td>Clarion CII</td></tr><tr><td>S... | <table><tr><td>Subject</td><td>Gender</td><td>Age (yrs)</td><td>Etiology</td><td>Deafness (yrs)</td><td>CI side</td><td>CI experience (mos)</td><td>CVC (Ph%)</td><td>Implant</td></tr><tr><td>S1</td><td>Male</td><td>60</td><td>Familial</td><td>46</td><td>Left</td><td>160</td><td>93</td><td>Clarion CII</td></tr><tr><td>S... | <table><tr><td>Subject</td><td>Gender</td><td>Age (yrs)</td><td>Etiology</td><td>Deafness (yrs)</td><td>CI side</td><td>CI experience (mos)</td><td>CVC (Ph%)</td><td>Implant</td></tr><tr><td>S10</td><td>Female</td><td>59</td><td>Type II Usher</td><td>4</td><td>Right</td><td>46</td><td>89</td><td>HiRes 90K</td></tr><tr>... |
19c1f36d44df02607910e521928ba9f125bf43cdca9a704c7f537fb3ea53fbbf.png | complex | <table><tr><td>Item</td><td colspan="2">Strongly Agree/Agree</td><td>QPCCC Subscale</td></tr><tr><td></td><td><i>n</i></td><td>% <sup>1</sup> (95% CIs)</td><td></td></tr><tr><td>The staff at the hospital showed respect for me</td><td>191</td><td>91.0 (87.1–94.8)</td><td>Respectful communication</td></tr><tr><td>T... | <table><tr><td>Item</td><td colspan="2">Strongly Agree/Agree</td><td>QPCCC Subscale</td></tr><tr><td></td><td>n</td><td>% 1 (95% CIs)</td><td></td></tr><tr><td>The staff at the hospital showed respect for me</td><td>191</td><td>91.0 (87.1–94.8)</td><td>Respectful communication</td></tr><tr><td>The staff at the hospital... | <table><tr><td>Item</td><td colspan="2">Strongly Agree/Agree</td><td>QPCCC Subscale</td></tr><tr><td></td><td>n</td><td>% 1 (95% CIs)</td><td></td></tr><tr><td>During my treatment, staff at the hospital gave me consistent information about my treatment</td><td>169</td><td>80.9 (75.5–86.2)</td><td>Treatment delivery</td... |
6e1d4aecae66f6ac94ccb71cd55a85c026837741a963e884d567f5489fce6251.png | complex | <table><tr><td rowspan="3">Place</td><td colspan="2">Age (years)</td><td colspan="2">Level of education (years of study)</td><td colspan="2">Income (R$)</td></tr><tr><td>Average</td><td>95%CI</td><td>Average</td><td>95%CI</td><td>Average</td><td>95%CI</td></tr><tr><td>Supermarket</td><td>29.8</td><td>29.2–30.3</t... | <table><tr><td rowspan="3">Place</td><td colspan="2">Age (years)</td><td colspan="2">Level of education (years of study)</td><td colspan="2">Income (R$)</td></tr><tr><td>Average</td><td>95%CI</td><td>Average</td><td>95%CI</td><td>Average</td><td>95%CI</td></tr><tr><td colspan="6"></td></tr><tr><td>Supermarket</td><td>2... | <table><tr><td rowspan="3">Place</td><td colspan="2">Age (years)</td><td colspan="2">Level of education (years of study)</td><td colspan="2">Income (R$)</td></tr><tr><td>Average</td><td>95%CI</td><td>Average</td><td>95%CI</td><td>Average</td><td>95%CI</td></tr><tr><td colspan="6"></td></tr><tr><td>er places</td><td>.2<... |
b73330801196b0b2ae46a49103d4685bbc43ba6c4104f79491352a6059bb1a96.png | complex | <table><tr><td></td><td>Name</td><td colspan="2">Screening</td><td colspan="8">Intervention</td><td>Follow-up</td></tr><tr><td></td><td>Duration</td><td colspan="2">12 months</td><td colspan="8">6 months</td><td>6 months</td></tr><tr><td>Visits</td><td>Time</td><td></td><td>Surgery</td><td>Days 1–3</td><td>Wk 2</... | <table><tr><td></td><td>Name</td><td colspan="2">Screening</td><td colspan="8">Intervention</td><td>Follow-up</td></tr><tr><td></td><td>Duration</td><td colspan="2">12 months</td><td colspan="8">6 months</td><td>6 months</td></tr><tr><td>Visits</td><td>Time</td><td></td><td>Surgery</td><td>Days 1–3</td><td>Wk 2</td><td... | <table><tr><td rowspan="4">Blood parameter</td><td>Liver</td><td>X</td><td></td><td>X</td><td></td><td>X</td><td></td><td></td><td>X</td><td>X</td></tr><tr><td>Inflammation</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td>Insulin resistance</td><td>X</td><td>X</... |
634964e8214d786ad7cd4256e360560644a751ca7b4958c427e8c8028776c966.png | complex | <table><tr><td rowspan="2">Drug category</td><td rowspan="2">Drug name</td><td colspan="2">Prescribed acutely</td><td colspan="2">Prescribed on discharge</td></tr><tr><td>No.</td><td>%</td><td>No.</td><td>%</td></tr><tr><td rowspan="4">Antiplatelet drugs</td><td>Aspirin</td><td>521</td><td>37.0</td><td>670</td><td>47.7... | <table><tr><td rowspan="2">Drug category</td><td rowspan="2">Drug name</td><td colspan="2">Prescribed acutely</td></tr><tr><td>No.</td><td>%</td></tr><tr><td rowspan="4">Antiplatelet drugs</td><td>Aspirin</td><td>521</td><td>37.0</td></tr><tr><td>Clopidogrel</td><td>50</td><td>3.6</td></tr><tr><td>Dipyridamole</td><td>... | <table><tr><td colspan="2">Prescribed on discharge</td></tr><tr><td>No.</td><td>%</td></tr><tr><td>670</td><td>47.7</td></tr><tr><td>66</td><td>4.7</td></tr><tr><td>13</td><td>0.9</td></tr><tr><td>12</td><td>0.9</td></tr><tr><td>n/a</td><td></td></tr><tr><td>49</td><td>3.5</td></tr><tr><td>n/a</td><td></td></tr><tr><td... |
44d1411477e583e1b57de2de2782a044046524997f3881d3ab2374a3bfef569a.png | simple | <table><tr><td>Boys</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Special</td><td>New</td><td>Fashionable</td><td>Natural</td><td>Local</td><td>T city</td><td>T countryside</td></tr><tr><td>Biscuits and ice creams</td><td>65.3</td><td>18.7</td><td>44.6</td><td>28.7</td><td>11.... | <table><tr><td>Boys</td><td></td><td></td><td></td></tr><tr><td></td><td>Special</td><td>New</td><td>Fashionable</td></tr><tr><td>Biscuits and ice creams</td><td>65.3</td><td>18.7</td><td>44.6</td></tr><tr><td>Bread and pasta</td><td>80.0</td><td>8.3</td><td>31.7</td></tr><tr><td>Chocolate and snacks</td><td>64.3</td><... | <table><tr><td></td><td></td><td></td><td></td></tr><tr><td>Natural</td><td>Local</td><td>T city</td><td>T countryside</td></tr><tr><td>28.7</td><td>11.2</td><td>35.1</td><td>11.2</td></tr><tr><td>73.3</td><td>16.7</td><td>23.3</td><td>10.0</td></tr><tr><td>31.5</td><td>11.1</td><td>38.2</td><td>4.5</td></tr><tr><td>74... |
6d96c0ebecc34ded0b5b7f1a28e0ace9cb5db316c066f8782b1554dab4be7499.png | complex | <table><tr><td colspan="7">599C>T GPX1 (rs1050450)</td></tr><tr><td></td><td></td><td colspan="2"></td><td></td><td colspan="2">Interaction</td></tr><tr><td></td><td></td><td>CC (<i>n</i> = 36)</td><td>CT + TT (<i>n</i> = 56)</td><td><i>p</i><sup>1</sup></td><td><i>F</i></td><td><i>p</i><sup>2</sup></td></tr><tr><td... | <table><tr><td colspan="2">599C>T GPX1 (rs1050450)</td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td rowspan="2">BMI (kg/m2)</td><td>Before</td></tr><tr><td>After</td></tr><tr><td rowspan="2">SBP (mgHg)</td><td>Before</td></tr><tr><td>After</td></tr><tr><td rowspan="2">DBP (mgHg)</td><td>Before</td... | <table><tr><td colspan="5">599C>T GPX1 (rs1050450)</td></tr><tr><td colspan="2"></td><td></td><td colspan="2">Interaction</td></tr><tr><td>CC (n = 36)</td><td>CT + TT (n = 56)</td><td>p1</td><td>F</td><td>p2</td></tr><tr><td>33 ± 5 31</td><td>35 ± 5 33</td><td>0.001</td><td>0.68</td><td>0.412</td></tr><tr><td>30 ± 3 30... |
b207d6a0086aef3df04b9d59da7912a864ccf5a25ec273e4baab06cc982967bf.png | complex | <table><tr><td rowspan="2">EtOH volume (ml)</td><td rowspan="2">Equation (1) diameter (nm)</td><td colspan="2">DLS</td><td colspan="2">SEM</td></tr><tr><td>Diameter (nm)</td><td>PDI</td><td>Diameter (nm)</td><td>SD</td></tr><tr><td>41</td><td>390</td><td>397</td><td>0.041</td><td>391</td><td>54</td></tr><tr><td>45</td>... | <table><tr><td rowspan="2">EtOH volume (ml)</td><td rowspan="2">Equation (1) diameter (nm)</td></tr><tr></tr><tr><td>41</td><td>390</td></tr><tr><td>45</td><td>360</td></tr><tr><td>47</td><td>346</td></tr><tr><td>50</td><td>326</td></tr><tr><td>53</td><td>307</td></tr><tr><td>55</td><td>295</td></tr><tr><td>57</td><td>... | <table><tr><td colspan="2">DLS</td><td colspan="2">SEM</td></tr><tr><td>Diameter (nm)</td><td>PDI</td><td>Diameter (nm)</td><td>SD</td></tr><tr><td>397</td><td>0.041</td><td>391</td><td>54</td></tr><tr><td>400</td><td>0.036</td><td>393</td><td>48</td></tr><tr><td>350</td><td>0.111</td><td>320</td><td>47</td></tr><tr><t... |
a21a4eeda8faa2c99a5196651d96b1da1bc9719bb0771af1a3200bfbe066fd50.png | complex | <table><tr><td rowspan="2" colspan="2">Phenotype</td><td colspan="3">Frequency (<i>n </i>(%))</td><td colspan="2">Genotype concordance (%)</td></tr><tr><td><i>HLA-B27</i>-positive<sup>α</sup></td><td>rs4349859-positive<sup>b</sup></td><td>rs116488202-positive</td><td>rs4349859</td><td>rs116488202</td></tr><tr><td>... | <table><tr><td rowspan="2" colspan="2">Phenotype</td><td colspan="3">Frequency (n (%))</td><td colspan="2">Genotype concordance (%)</td></tr><tr><td>HLA-B27-positiveα</td><td>rs4349859-positiveb</td><td>rs116488202-positive</td><td>rs4349859</td><td>rs116488202</td></tr><tr><td>Controls</td><td>Caucasian</td><td>9/117 ... | <table><tr><td rowspan="2" colspan="2">Phenotype</td><td colspan="3">Frequency (n (%))</td><td colspan="2">Genotype concordance (%)</td></tr><tr><td>HLA-B27-positiveα</td><td>rs4349859-positiveb</td><td>rs116488202-positive</td><td>rs4349859</td><td>rs116488202</td></tr><tr><td></td><td>New Zealand Māori</td><td>7/107... |
25438f0c11f997ca96753f915d1248de6e87fbca7ecba00c84d7257bb1d7de57.png | simple | <table><tr><td>Plant extracts</td><td>IC<sub>50</sub> values (<i>μ</i>g/mL) ± SD</td><td>Vitamin C equivalents for a 200 mg capsule (in g)</td></tr><tr><td>(1) <i>Rosmarinus officinalis</i> (McConnell's Blue)</td><td>3.48 ± 0.22</td><td>0.351</td></tr><tr><td>(2) <i>Rosmarinus officinalis</i> (Tuscan Blu... | <table><tr><td>Plant extracts</td><td>IC50 values (μg/mL) ± SD</td><td>Vitamin C equivalents for a 200 mg capsule (in g)</td></tr><tr><td>(1) Rosmarinus officinalis (McConnell's Blue)</td><td>3.48 ± 0.22</td><td>0.351</td></tr><tr><td>(2) Rosmarinus officinalis (Tuscan Blue)</td><td>10.84 ± 0.12</td><td>1.09</td></tr><... | <table><tr><td>-intermedia (Margaret Roberts)</td><td>0</td><td></td></tr><tr><td>(4) Lavandula spica</td><td>125.5 ± 1.8</td><td>12.67</td></tr><tr><td>(5) Origanum vulgare</td><td>26.43 ± 1.58</td><td>2.67</td></tr><tr><td>(6) Petroselinum crispum</td><td>53.3 ± 2.63</td><td>5.38</td></tr><tr><td>(7) Laurus nobilis</... |
2f7d31924913c78bcff7b69079171fcf201250717a3e8c31b0a5ebb2de462282.png | complex | <table><tr><td></td><td>Standard low-fat diet</td><td>DHA low-fat diet</td><td>High saturated fat diet</td></tr><tr><td><i>N</i></td><td>18</td><td>20</td><td>19</td></tr><tr><td>Initial body mass (g)</td><td>318 ± 7</td><td>323 ± 4</td><td>323 ± 5</td></tr><tr><td>Final body mass (g)</td><td>488 ± ... | <table><tr><td></td><td>Standard low-fat diet</td><td>DHA low-fat diet</td><td>High saturated fat diet</td></tr><tr><td>N</td><td>18</td><td>20</td><td>19</td></tr></table> | <table><tr><td></td><td>Standard low-fat diet</td><td>DHA low-fat diet</td><td>High saturated fat diet</td></tr><tr><td>Initial body mass (g)</td><td>318 ± 7</td><td>323 ± 4</td><td>323 ± 5</td></tr><tr><td>Final body mass (g)</td><td>488 ± 10</td><td>494 ± 8</td><td>554 ± 111,2</td></tr><tr><td>Change in body mass (g)... |
3c5d440b87456f423ddabf78bda209c5408e91a9d4bed5330a2df7cd45589a7e.png | simple | <table><tr><td>Patient</td><td>Gender</td><td>Basal CD4<sup>+</sup>(cells/mm<sup>3</sup>)</td><td>HCV VL range (log<sub>10</sub> UI/mL)<sup>†</sup></td><td>Fibrosis grade (METAVIR score)</td><td>Response to IFN-based therapy</td><td>Sampling times<sup><i>∗</i></sup></td></tr><tr><td>A</td><td>F</td><td>U</t... | <table><tr><td>Patient</td><td>Gender</td><td>Basal CD4+(cells/mm3)</td><td>HCV VL range (log10 UI/mL)†</td><td>Fibrosis grade (METAVIR score)</td><td>Response to IFN-based therapy</td><td>Sampling times∗</td></tr><tr><td>A</td><td>F</td><td>U</td><td><2.78–6.5</td><td>0</td><td>R</td><td>0, 24 h, 4 wk, 12 wk, 24 wk, 4... | <table><tr><td>K</td><td>M</td><td>400</td><td>6.4–6.7</td><td>4</td><td>NR</td><td>0, 24 h, 4 wk, 12 wk</td></tr><tr><td>L</td><td>M</td><td>625</td><td>5.9–7.4</td><td>3</td><td>NR</td><td>0, 24 h, 4 wk, 12 wk</td></tr><tr><td>M</td><td>M</td><td>414</td><td>4.2–6.3</td><td>3</td><td>NR</td><td>0, 24 h, 4 wk, 12 wk, ... |
fd1ee683b23db2a301c10f9ce5f2a4fbe514dc7e913fbd5ea957524bcfde8ee1.png | simple | <table><tr><td>Disease location</td><td>Cases(<i>n</i> = 94)</td><td>Sensitivity(%)</td><td>Specificity(%)</td><td>PPV(%)</td><td>NPV(%)</td><td>Accuracy(%)</td></tr><tr><td>Endometriomas</td><td>57 (60.6%)</td><td>100</td><td>100</td><td>100</td><td>100</td><td>100</td></tr><tr><td>Bladder nodules</td><td>11 (11.7%)</... | <table><tr><td>Disease location</td><td>Cases(n = 94)</td><td>Sensitivity(%)</td><td>Specificity(%)</td><td>PPV(%)</td><td>NPV(%)</td><td>Accuracy(%)</td></tr><tr><td>Endometriomas</td><td>57 (60.6%)</td><td>100</td><td>100</td><td>100</td><td>100</td><td>100</td></tr><tr><td>Bladder nodules</td><td>11 (11.7%)</td><td>... | <table><tr><td>Vaginal nodules</td><td>39 (41.5%)</td><td>92.3</td><td>98.2</td><td>97.3</td><td>94.7</td><td>95.7</td></tr><tr><td>Pouch of Douglas obliteration</td><td>48 (51.1%)</td><td>93.8</td><td>91.3</td><td>91.8</td><td>93.3</td><td>92.5</td></tr><tr><td>Bowel lesions (rectum, sigma, POD)</td><td>20 (21.3%)</td... |
b89877003aa202921b9bac11669ef1252ee7cc802ca350338ccb57a155710203.png | complex | <table><tr><td rowspan="2"></td><td colspan="4">Phenolic Acid Intake</td><td rowspan="2"><i>p</i></td></tr><tr><td>Q1 (Median = 120.36)</td><td>Q2 (Median = 205.39)</td><td>Q3 (Median = 307.70)</td><td>Q4 (Median = 522.26)</td></tr><tr><td>Sex, <i>n</i> (%)</td><td></td><td></td><td></td><td></td><td>0.919</td></tr><tr... | <table><tr><td rowspan="2"></td><td colspan="4">Phenolic Acid Intake</td><td rowspan="2"></td></tr><tr><td>Q1 </td><td>Q2 </td><td>Q3</td><td>Q4 (Med</td></tr></table> | <table><tr><td></td><td>(Median = 120.36)</td><td>(Median = 205.39)</td><td> (Median = 307.70)</td><td>ian = 522.26)</td><td>p</td></tr><tr><td>Sex, n (%)</td><td></td><td></td><td></td><td></td><td>0.919</td></tr><tr><td>Male</td><td>186 (41.1)</td><td>197 (40.5)</td><td>215 (42.3)</td><td>206 (42.2)</td><td></td></tr... |
e9b1d32d2546852fdd1799c4ed94727402f6e7cd14f3632b890a5c60de346d12.png | complex | <table><tr><td colspan="2">Item</td><td>Number of Patients</td><td>Percentage (%)</td></tr><tr><td rowspan="2">Gender</td><td>Male</td><td>127</td><td>59.1</td></tr><tr><td>Female</td><td>88</td><td>40.9</td></tr><tr><td rowspan="2">Age</td><td><60</td><td>108</td><td>50.2</td></tr><tr><td>≥60</td><td>107</td>... | <table><tr><td colspan="2">Item</td></tr><tr><td rowspan="2">Gender</td><td>Male</td></tr><tr><td>Female</td></tr><tr><td rowspan="2">Age</td><td><60</td></tr><tr><td>≥60</td></tr><tr><td rowspan="2">Smoking history</td><td>Yes</td></tr><tr><td>No</td></tr><tr><td rowspan="2">Disease staging</td><td>Stage IIIB</td></tr... | <table><tr><td>Number of Patients</td><td>Percentage (%)</td></tr><tr><td>127</td><td>59.1</td></tr><tr><td>88</td><td>40.9</td></tr><tr><td>108</td><td>50.2</td></tr><tr><td>107</td><td>49.8</td></tr><tr><td>95</td><td>44.2</td></tr><tr><td>120</td><td>55.8</td></tr><tr><td>36</td><td>16.7</td></tr><tr><td>179</td><td... |
37e7e452440fa4576ef24d2370509cc5a9e2cf0d7a36ec91495e347ba5112eab.png | complex | <table><tr><td>Name<sup>a</sup></td><td>Age</td><td>Regular medication prior to trial</td><td>Trial completion</td><td>Result of trial</td><td>Treatment decision</td></tr><tr><td colspan="6"><i>Standard vs heat retaining knee support – trials commencing December 2001 to February 2002</i></td></tr><tr><td>Ann</td>... | <table><tr><td>Namea</td><td>Age</td><td>Regular medication prior to trial</td><td>Trial completion</td><td>Result of trial</td></tr><tr><td colspan="5">Standard vs heat retaining knee support – trials commencing December 2001 to February 2002</td></tr><tr><td>Ann</td><td>67</td><td>solpadol, meloxicam, amitryptiline</... | <table><tr><td>Treatment decision</td></tr><tr><td>Standard vs heat retaining knee support – trials commencing December 2001 to February 2002</td></tr><tr><td>Continued use of heat retaining support</td></tr><tr><td>No further use of supports</td></tr><tr><td>Continued use of heat retaining support</td></tr><tr><td>No ... |
d452c2e639f6584c49ad158e264ab73e336ee2f963c0a2dcb723ac3d2acfd5dc.png | simple | <table><tr><td>Skin cancer</td><td>TGF-<i>β</i></td><td>uPA/uPAR</td></tr><tr><td>BCC</td><td>−/+</td><td>?</td></tr><tr><td>SCC</td><td>++</td><td>++</td></tr><tr><td>Melanoma</td><td>−/+</td><td>++</td></tr></table> | <table><tr><td>Skin cancer</td></tr><tr><td>BCC</td></tr><tr><td>SCC</td></tr><tr><td>Melanoma</td></tr></table> | <table><tr><td>TGF-β</td><td>uPA/uPAR</td></tr><tr><td>−/+</td><td>?</td></tr><tr><td>++</td><td>++</td></tr><tr><td>−/+</td><td>++</td></tr></table> |
c7ea0b4a6d566244ba4a306bbbebcf58588d3053cac2f0437fc6a6bc11ca7f6a.png | simple | <table><tr><td>Motif family</td><td>Heart</td><td>Sperm</td></tr><tr><td>E2F<sup>1</sup></td><td>Hypo-methylated</td><td>Hypo-methylated</td></tr><tr><td>NFY<sup>1</sup></td><td>Hypo-methylated</td><td>Hypo-methylated</td></tr><tr><td>YY1<sup>1</sup></td><td>Hypo-methylated</td><td>Hypo-methylated</td></tr><tr><td>MYCM... | <table><tr><td>Motif family</td><td>Heart</td><td>Sperm</td></tr><tr><td>E2F1</td><td>Hypo-methylated</td><td>Hypo-methylated</td></tr><tr><td>NFY1</td><td>Hypo-methylated</td><td>Hypo-methylated</td></tr><tr><td>YY11</td><td>Hypo-methylated</td><td>Hypo-methylated</td></tr><tr><td>MYCMAX1</td><td>Hypo-methylated</td><... | <table><tr><td>SREBP3</td><td>Hypo-methylated</td><td>Neutral</td></tr><tr><td>SRF2</td><td>Hypo-methylated</td><td>Neutral</td></tr><tr><td>STAT4</td><td>Hypo-methylated</td><td>Neutral</td></tr><tr><td>TCF1</td><td>Hypo-methylated</td><td>Neutral</td></tr><tr><td>GATA1</td><td>Neutral</td><td>Hyper-methylated</td></t... |
ae51bc2edcabfd61e89161ac169356e6c4a59982b5b728110e7d7b3cdb44cc6c.png | complex | <table><tr><td> </td><td>Features or characteristics</td><td>Total</td></tr><tr><td rowspan="2">Diagnosed with infection in pregnancy</td><td>Infant with CRI but no CRS features at birth</td><td>3</td></tr><tr><td>Infant with CRI resulting in CRS</td><td>5</td></tr><tr><td>Diagnosed after birth</td><td>Infant with CRI ... | <table><tr><td></td><td>Features or characteristics</td></tr><tr><td rowspan="2">Diagnosed with infection in pregnancy</td><td>Infant with CRI but no CRS features at birth</td></tr><tr><td>Infant with CRI resulting in CRS</td></tr><tr><td>Diagnosed after birth</td><td>Infant with CRI resulting in CRS</td></tr><tr><td r... | <table><tr><td>Total</td></tr><tr><td>3</td></tr><tr><td>5</td></tr><tr><td>7</td></tr><tr><td>8</td></tr><tr><td>6</td></tr><tr><td>1</td></tr><tr><td>14</td></tr><tr><td>1</td></tr><tr><td>2</td></tr><tr><td>10</td></tr><tr><td>8</td></tr><tr><td>3</td></tr><tr><td>10</td></tr><tr><td>3</td></tr><tr><td>5</td></tr></... |
1941aa1e141d98cca61e1fa85b551158bedbcfaf71ed8b41f09a8cef05c823fa.png | simple | <table><tr><td>Extraction methods</td><td>Abbreviation</td><td>Crude extract (mg/g herb)</td></tr><tr><td>Heat reflux extraction using water</td><td>HRE-W</td><td>297.4 ± 28.4</td></tr><tr><td>Microwave-assisted extraction using water</td><td>MAE-W</td><td>390.8 ± 16.6***</td></tr><tr><td>Ultrasonic extractio... | <table><tr><td>Extraction methods</td></tr><tr><td>Heat reflux extraction using water</td></tr><tr><td>Microwave-assisted extraction using water</td></tr><tr><td>Ultrasonic extraction using ethanol (70 % vol/vol)</td></tr><tr><td>Ultrasonic extraction using water</td></tr></table> | <table><tr><td>Abbreviation</td><td>Crude extract (mg/g herb)</td></tr><tr><td>HRE-W</td><td>297.4 ± 28.4</td></tr><tr><td>MAE-W</td><td>390.8 ± 16.6***</td></tr><tr><td>UE-E</td><td>327.4 ± 19.4</td></tr><tr><td>UE-W</td><td>275.0 ± 9.0</td></tr></table> |
437802043c57c57c02706a38630c9f573b0980e4fa3473f2df1f7bb758d9876c.png | complex | <table><tr><td>Treatment</td><td colspan="3"><i>S. aureus</i> NCTC 13297</td><td colspan="3"><i>P. aeruginosa</i> NCTC 10781</td><td colspan="3">Co-culture</td></tr><tr><td></td><td>Concentration</td><td>Mean OD</td><td>Biofilm</td><td>Concentration</td><td>Mean OD</td><td>Biofilm</td><td>Concentration</td><td>Mean OD<... | <table><tr><td>Treatment</td><td>S. aureus NCTC 13297</td></tr><tr><td></td><td>Concentration</td></tr><tr><td>Bacteria</td><td></td></tr><tr><td>BgAg</td><td>0.625%</td></tr><tr><td></td><td>0.15%</td></tr><tr><td>Bg</td><td>0.625%</td></tr><tr><td></td><td>0.15%</td></tr></table> | <table><tr><td colspan="2">S. aureus NCTC 13297</td><td colspan="3">P. aeruginosa NCTC 10781</td><td colspan="3">Co-culture</td></tr><tr><td>Mean OD</td><td>Biofilm</td><td>Concentration</td><td>Mean OD</td><td>Biofilm</td><td>Concentration</td><td>Mean OD</td><td>Biofilm</td></tr><tr><td>0.1</td><td>Moderate</td><td><... |
7a0ebe6c1a67396277db720d5dedefc7d66fd32bb170a16ccc16c7277998348b.png | complex | <table><tr><td rowspan="2">Source of variations</td><td rowspan="2">Degree of freedom</td><td colspan="5">Mean square</td></tr><tr><td>pH</td><td>Exchangeable acidity</td><td>Exchangeable Al</td><td>Exchangeable Fe</td><td>Exchangeable Ca</td></tr><tr><td>Treatments</td><td>4</td><td>3.71∗</td><td>0.23∗</td... | <table><tr><td rowspan="2">Source of variations</td><td rowspan="2">Degree of freedom</td><td colspan="5">Mean square</td></tr><tr><td>pH</td><td>Exchangeable acidity</td><td>Exchangeable Al</td><td>Exchangeable Fe</td><td>Exchangeable Ca</td></tr><tr><td>Treatments</td><td>4</td><td>3.71∗</td><td>0.23∗</td><td>0.08∗</... | <table><tr><td rowspan="2">Source of variations</td><td rowspan="2">Degree of freedom</td><td colspan="5">Mean square</td></tr><tr><td>pH</td><td>Exchangeable acidity</td><td>Exchangeable Al</td><td>Exchangeable Fe</td><td>Exchangeable Ca</td></tr><tr><td>Treatments ∗ time</td><td>8</td><td>0.76∗</td><td>0.34∗</td><td>... |
113d7ff2af88eec25e072f2bfff12e74f2f37eec528617aedb4920f7d4b76ec9.png | simple | <table><tr><td>EC identifier</td><td>Enzyme name</td><td>Pathway</td><td>Reference</td></tr><tr><td>2.1.3.3</td><td>Ornithine carbamoyltransferase</td><td>Arginine/Proline</td><td>Cook et al (2007)</td></tr><tr><td>2.3.1.57</td><td>Diamine <i>N</i>-acetyltransferase</td><td>Polyamines</td><td>Cook et al (2007)</td></tr... | <table><tr><td>EC identifier</td><td>Enzyme name</td><td>Pathway</td><td>Reference</td></tr><tr><td>2.1.3.3</td><td>Ornithine carbamoyltransferase</td><td>Arginine/Proline</td><td>Cook et al (2007)</td></tr><tr><td>2.3.1.57</td><td>Diamine N-acetyltransferase</td><td>Polyamines</td><td>Cook et al (2007)</td></tr><tr><t... | <table><tr><td>EC identifier</td><td>Enzyme name</td><td>Pathway</td><td>Reference</td></tr><tr><td>4.2.1.75</td><td>Uroporphyrinogen-III synthase</td><td>Porphyrin</td><td>Seeber et al (2008)</td></tr><tr><td>4.2.1.99</td><td>2-Methylisocitrate dehydratase</td><td>MC cycle</td><td>Seeber et al (2008)</td></tr><tr><td>... |
8da7dcac5e49969d5e15ec914b42a4ad7e77df39e1e03794aa0f128e65a81b09.png | simple | <table><tr><td>Meeting/ Event (Date)</td><td>Alcohol industry</td><td>Tobacco industry</td></tr><tr><td>Informal Discussion meeting for Chairmen & Directors of Large Organisations held at BAT offices (1966)</td><td>Courage, Barclay Simmonds</td><td>BAT, Gallaher</td></tr><tr><td>Practical Skills of Managing People ... | <table><tr><td>Meeting/ Event (Date)</td><td>Alcohol industry</td></tr><tr><td>Informal Discussion meeting for Chairmen & Directors of Large Organisations held at BAT offices (1966)</td><td>Courage, Barclay Simmonds</td></tr><tr><td>Practical Skills of Managing People (1981)</td><td>Allied, Bass, Charrington, S&N</td><... | <table><tr><td>Tobacco industry</td></tr><tr><td>BAT, Gallaher</td></tr><tr><td>BAT</td></tr><tr><td>BAT</td></tr><tr><td>BAT</td></tr><tr><td>BAT</td></tr><tr><td>BAT</td></tr><tr><td>The Tobacco Duty Free Group</td></tr><tr><td>Imperial, Rothmans</td></tr><tr><td>BAT</td></tr><tr><td>BAT</td></tr></table> |
771da3024860d75f89e671511c1c743cf164eab4bebbde0ff0da4139bc833b09.png | complex | <table><tr><td rowspan="2">Matrix</td><td colspan="4">GlcNAc</td><td colspan="4">GalNAc</td></tr><tr><td>EC<sup>a</sup></td><td>FC<sup>b</sup></td><td>Recovery (%)</td><td>RSD<sup>c</sup></td><td>EC<sup>a</sup></td><td>FC<sup>b</sup></td><td>Recovery (%)</td><td>RSD<sup>c</sup></td></tr><tr><td rowspan="3">Raw milk</td... | <table><tr><td rowspan="2">Matrix</td><td colspan="4">GlcNAc</td><td colspan="4">GalNAc</td></tr><tr><td>ECa</td><td>FCb</td><td>Recovery (%)</td><td>RSDc</td><td>ECa</td><td>FCb</td><td>Recovery (%)</td><td>RSDc</td></tr><tr><td rowspan="3">Raw milk</td><td rowspan="3">152.3 ± 3.4</td><td>30.0</td><td>102.06</td><td>1... | <table><tr><td rowspan="2">Yoghurt</td><td rowspan="2"> ± 11.1</td><td>0.0</td><td></td><td>9</td><td rowspan="2">± 5.5</td><td>5.0</td><td>0.58</td><td>.92</td></tr><tr><td>120.0</td><td>100.81</td><td>1.03</td><td>50.0</td><td>99.79</td><td>0.62</td></tr><tr><td rowspan="3">Infant formula</td><td rowspan="3">720.0 ± ... |
e665b9bfbd55f55b74d16dd57e2ddb2f12da1072ad1d8dd3b7434b9c21cace6d.png | complex | <table><tr><td>Determinants</td><td>Odds ratio</td><td>Changeability<sup>a</sup></td><td>Category</td><td>Target group<sup>b</sup></td></tr><tr><td colspan="5">Demographic</td></tr><tr><td>Age >40 years</td><td>2.65</td><td>-</td><td>Not applicable</td><td>Not applicable</td></tr><tr><td>Chronic illness</td><td>3.37... | <table><tr><td>Determinants</td></tr><tr><td>Demographic</td></tr><tr><td>Age >40 years</td></tr><tr><td>Chronic illness</td></tr><tr><td>Behavioural</td></tr><tr><td>Aware of personal risk for influenza infection</td></tr><tr><td>Aware of risk of infecting patients</td></tr><tr><td>‘Vaccination reduces risk of infecti... | <table><tr><td>Odds ratio</td><td>Changeabilitya</td><td>Category</td><td>Target groupb</td></tr><tr><td colspan="4">Demographic</td></tr><tr><td>2.65</td><td>-</td><td>Not applicable</td><td>Not applicable</td></tr><tr><td>3.37</td><td>-</td><td>Not applicable</td><td>Not applicable</td></tr><tr><td colspan="4">Behavi... |
56ea87a5ecc3b7cd8078c2251c28604cf3edef177e6bce6affcb128fea9247d6.png | simple | <table><tr><td>Rank</td><td>rs ID</td><td>pval</td><td>Gene Sym</td><td>Gene Name</td><td>SNP Function</td></tr><tr><td>1.0</td><td>rs10018625</td><td>0.001536</td><td>TAG ERROR</td><td>TAG ERROR</td><td>unknown, TAG ERROR</td></tr><tr><td>2.0</td><td>rs1047643</td><td>0.001603</td><td>FDFT1</td><td>Farnesyl-diphosphat... | <table><tr><td>Rank</td><td>rs ID</td><td>pval</td><td>Gene Sym</td><td>Gene Name</td><td>SNP Function</td></tr><tr><td>1.0</td><td>rs10018625</td><td>0.001536</td><td>TAG ERROR</td><td>TAG ERROR</td><td>unknown, TAG ERROR</td></tr><tr><td>2.0</td><td>rs1047643</td><td>0.001603</td><td>FDFT1</td><td>Farnesyl-diphosphat... | <table><tr><td>5.0</td><td></td><td>.002362</td><td>STYK1</td><td>otein kinase STYK1</td><td>oding-nonsynon</td></tr><tr><td>6.0</td><td>rs1801133</td><td>0.003251</td><td>MTHFR</td><td>5, 10-methylenetetrahydrofolate reductase (NADPH)</td><td>coding-nonsynon</td></tr><tr><td>7.0</td><td>rs2069456</td><td>0.003375</td>... |
11aeb210942d3efbfeb52a8b25ed0d38963de3d34ba22b6c1f78baf2a283d834.png | simple | <table><tr><td>Variable</td><td>All participants<sup>a</sup></td><td>Group 1 (N=21)</td><td>Group 2 (N=21)</td><td>p value<sup>b</sup></td></tr><tr><td>Women N</td><td>39</td><td>19 (90%)</td><td>20 (95%)</td><td>0.55</td></tr><tr><td>College degree or higher N</td><td>40</td><td>20 (95%)</td><td>20 (95%)</td><td>0.32<... | <table><tr><td>Variable</td><td>All participantsa</td><td>Group 1 (N=21)</td><td>Group 2 (N=21)</td><td>p valueb</td></tr><tr><td>Women N</td><td>39</td><td>19 (90%)</td><td>20 (95%)</td><td>0.55</td></tr><tr><td>College degree or higher N</td><td>40</td><td>20 (95%)</td><td>20 (95%)</td><td>0.32</td></tr><tr><td>White... | <table><tr><td>Variable</td><td>All participantsa</td><td>Group 1 (N=21)</td><td>Group 2 (N=21)</td><td>p valueb</td></tr><tr><td>Weight (kg)</td><td>76.9 (19.8)</td><td>78.0 (22.6)</td><td>75.7 (17.1)</td><td>0.71</td></tr><tr><td>BMI</td><td>27.6 (6.0)</td><td>27.7 (6.4)</td><td>27.5 (5.8)</td><td>0.90</td></tr><tr><... |
0b4eb3f2986b2ef1fcefc12bc9e82bef8b406af0de6f09d4283a73e4dce55fc0.png | complex | <table><tr><td></td><td colspan="3">Total</td><td colspan="3">Male</td><td colspan="3">Female</td></tr><tr><td></td><td>CAD patients</td><td>Control subjects</td><td><i>P</i> Value</td><td>CAD patients</td><td>Control subjects</td><td><i>P</i> Value</td><td>CAD patients</td><td>Control subjects</td><td><i>P</i> Value</... | <table><tr><td></td><td colspan="3">Total</td><td colspan="3">Male</td><td colspan="3">Female</td></tr><tr><td></td><td>CAD patients</td><td>Control subjects</td><td>P Value</td><td>CAD patients</td><td>Control subjects</td><td>P Value</td><td>CAD patients</td><td>Control subjects</td><td>P Value</td></tr><tr><td>Numbe... | <table><tr><td>/L)</td><td> ± 0.043</td><td> 0.050</td><td>0.010*</td><td>.048</td><td> 0.059</td><td>000*</td><td>.076</td><td>0 ± 0.071</td><td>.040*</td></tr><tr><td>HDL-C(mmol/L)</td><td>0.92 ± 0.019</td><td>1.22 ± 0.062</td><td>0.001*</td><td>0.91 ± 0.021</td><td>1.24 ± 0.045</td><td>0.000*</td><td>0.94 ± 0.033</t... |
93c1a1d92e85b1c30f80ae10111863301a0ebed7403dfec1adf0dd600d46cb87.png | simple | <table><tr><td> </td><td>AA-MF</td><td>GMP-MF</td><td><i>p</i></td></tr><tr><td><i>Energy</i></td><td> </td><td> </td><td> </td></tr><tr><td> kcal/d</td><td>2,266 ± 263</td><td>2,566 ± 204</td><td>0.26</td></tr><tr><td>kcal from MF/d</td><td>544 ± 100</td><td>763 ± 118</td><td>0.049</td></tr><tr><td... | <table><tr><td></td><td>AA-MF</td><td>GMP-MF</td><td>p</td></tr><tr><td>Energy</td><td></td><td></td><td></td></tr><tr><td>kcal/d</td><td>2,266 ± 263</td><td>2,566 ± 204</td><td>0.26</td></tr><tr><td>kcal from MF/d</td><td>544 ± 100</td><td>763 ± 118</td><td>0.049</td></tr><tr><td>kcal from NF/d</td><td>1,722 ± 229</td... | <table><tr><td>g protein from NF/d</td><td>21 ± 2</td><td>26 ± 4</td><td>0.32</td></tr><tr><td>Calcium : phosphorus ratio3</td><td></td><td></td><td></td></tr><tr><td>Ca : P ratio/d</td><td>1.06 ± 0.14</td><td>1.19 ± 0.17</td><td>0.13</td></tr><tr><td>Ca : P ratio from MF/d</td><td>0.96 ± 0.14</td><td>1.22 ± 0.04</td><... |
5426c25300c3dc36fdeb2ca4854efc5846d5c27c66458ebe1b471c173a4456cc.png | complex | <table><tr><td rowspan="2">Category</td><td>Male (<i>n</i> = 129)</td><td>Female (<i>n</i> = 108)</td><td rowspan="2"><i>P</i>-value</td></tr><tr><td>Mean (sd)</td><td>Mean (sd)</td></tr><tr><td>Confidence to undertake endodontic treatment</td><td>11.34 (2.65)</td><td>09.87 (2.83)</td><td>0.001*</td></tr><tr><td>Traini... | <table><tr><td rowspan="2">Category</td><td>Male (n = 129)</td><td>Female (n = 108)</td><td rowspan="2">P-value</td></tr><tr><td>Mean (sd)</td><td>Mean (sd)</td></tr></table> | <table><tr><td>Confidence to undertake endodontic treatment</td><td>11.34 (2.65)</td><td>09.87 (2.83)</td><td>0.001*</td></tr><tr><td>Training/Support for undertaking more endodontic treatment in NHS primary dental care</td><td>11.33 (2.48)</td><td>11.12 (2.41)</td><td>0.51</td></tr><tr><td>Dissatisfaction with endodon... |
69152c463b6e3d824aa41cf90ae880edfd54f22357ff6cca72c3b244da6d37ec.png | simple | <table><tr><td>Characteristic</td><td>Full Cohort(n = 309) †</td><td>Excluded(n = 199) †</td><td>One Month Analysis Sample(n = 110) ‡</td><td>P-value††</td></tr><tr><td></td><td>Mean (SD) or n (%)</td><td>Mean (SD) or n (%)</td><td>Mean (SD) or n (%)</td><td></td></tr><tr><td>Age in years<... | <table><tr><td>Characteristic</td><td>Full Cohort(n = 309) †</td><td>Excluded(n = 199) †</td><td>One Month Analysis Sample(n = 110) ‡</td><td>P-value††</td></tr><tr><td></td><td>Mean (SD) or n (%)</td><td>Mean (SD) or n (%)</td><td>Mean (SD) or n (%)</td><td></td></tr><tr><td>Age in years</td><td>74.7 (8.5)</td><td>75.... | <table><tr><td>Total days of delirium (IQR)****</td><td>5 (6)</td><td>6 (9)</td><td>1 (3)</td><td><0.0001</td></tr></table> |
70b825cc5507e452f3740b8f7d7c06a1c4483c152ab309c446b114be58989e5a.png | complex | <table><tr><td colspan="2">PM/DM-ILD (n = 116)</td><td>Infection (n = 38)</td><td>Non-infection (n = 78)</td><td><i>P</i> value</td></tr><tr><td colspan="2">Women (<i>n</i> (%))</td><td>24/38 (63.2%)</td><td>59/78 (75.6%)</td><td>0.16</td></tr><tr><td colspan="2">Type (<i>n</i>)</td><td>PM 7, DM 24, CADM 7</td><td>PM 1... | <table><tr><td colspan="2">PM/DM-ILD (n = 116)</td><td>Infection (n = 38)</td><td>Non-infection (n = 78)</td><td>P value</td></tr><tr><td colspan="2">Women (n (%))</td><td>24/38 (63.2%)</td><td>59/78 (75.6%)</td><td>0.16</td></tr><tr><td colspan="2">Type (n)</td><td>PM 7, DM 24, CADM 7</td><td>PM 15, DM 27, CADM 36</td... | <table><tr><td rowspan="2">Baseline data</td><td>Albumin (g/dl)</td><td>3.18 ± 0.52c</td><td>3.53 ± 0.55c</td><td>0.003**</td></tr><tr><td>PaCO2 (mmHg)</td><td>36.0 (31.5–38.8)d</td><td>38.0 (35.5–41.5)d</td><td>0.016*</td></tr><tr><td rowspan="5">HRCT</td><td>Zone A</td><td>1.0 (0–2.0)d</td><td>1.0 (0–1.0)d</td><td>0.... |
22e1078af499c940c190780fd6807d288e1815a191ee4dba3828fd5298a4a05c.png | complex | <table><tr><td></td><td></td><td></td><td colspan="2">MF (<i>ε </i>= 10)</td><td colspan="2">PHIA (<i>ε </i>= 14)</td></tr><tr><td>PDB code</td><td>Name</td><td>length</td><td>low energy</td><td>high score</td><td>low energy</td><td>high scoring</td></tr><tr><td>1gcq(B)</td><td>Grb2</td><td>57</td><td>37.2</t... | <table><tr><td></td><td></td><td></td><td colspan="2">MF (ε = 10)</td><td colspan="2">PHIA (ε = 14)</td></tr><tr><td>PDB code</td><td>Name</td><td>length</td><td>low energy</td><td>high score</td><td>low energy</td><td>high scoring</td></tr><tr><td>1gcq(B)</td><td>Grb2</td><td>57</td><td>37.2</td><td>49.5</td><td>36.1<... | <table><tr><td></td><td></td><td></td><td colspan="2">MF (ε = 10)</td><td colspan="2">PHIA (ε = 14)</td></tr><tr><td>PDB code</td><td>Name</td><td>length</td><td>low energy</td><td>high score</td><td>low energy</td><td>high scoring</td></tr><tr><td>1ad5</td><td>Hck kinase</td><td>58</td><td>22.6</td><td>38.4</td><td>23... |
e5abe3d8cf21356b3e8c4bb31f7d6f4d44047e304e7dabf387d8e3e2c30a05be.png | simple | <table><tr><td>Developmental stage</td><td>Water (n)</td><td>Zinc chloride (n)</td><td>Soybean root exudate (n)</td></tr><tr><td>3 cell</td><td>2.67 ± 1.15 (3)</td><td>3.24 ± 1.25 (4)</td><td>3.20 ± 1.3 (6)</td></tr><tr><td>4 cell</td><td>4.67 ± 2.08 (3)</td><td>5.33 ± 1.53 (3)</td><td>5.25 ... | <table><tr><td>Developmental stage</td><td>Water (n)</td><td>Zinc chloride (n)</td></tr><tr><td>3 cell</td><td>2.67 ± 1.15 (3)</td><td>3.24 ± 1.25 (4)</td></tr><tr><td>4 cell</td><td>4.67 ± 2.08 (3)</td><td>5.33 ± 1.53 (3)</td></tr><tr><td>Gastrula</td><td>75.71 ± 9.25 (6)</td><td>72.60 ± 1.51 (5)</td></tr><tr><td>Tadp... | <table><tr><td>Soybean root exudate (n)</td></tr><tr><td>3.20 ± 1.3 (6)</td></tr><tr><td>5.25 ± 0.96 (7)</td></tr><tr><td>70.60 ± 4.35 (7)</td></tr><tr><td>93.80 ± 5.77 (5)</td></tr><tr><td>107.72 ± 10.12 (10)</td></tr><tr><td>166.14 ± 10.16 (11)</td></tr></table> |
f1c6c919cca07ab54b684d0635b6c222b4270f1c145146d7f8e7490e4636fe57.png | simple | <table><tr><td>Citation</td><td>Mosquito Species</td><td>Diet Components</td><td>Success Rate</td></tr><tr><td>1955. Lea et al. [57]</td><td><i>Aedes aegypti</i>, <i>Ae. quadrimaculatus</i></td><td>Skimmed milk with 10% honey.</td><td>The authors state that skimmed milk can be a substitute for blood to produce eggs. <i... | <table><tr><td>Citation</td><td>Mosquito Species</td></tr><tr><td>1955. Lea et al. [57]</td><td>Aedes aegypti, Ae. quadrimaculatus</td></tr><tr><td>1955. Dimond et al. [58]</td><td>Aedes aegypti</td></tr><tr><td>1990. Kogan [56]</td><td>Aedes aegypti</td></tr><tr><td>1996. Cosgrove and Wood [59]</td><td>Aedes aegypti</... | <table><tr><td>Diet Components</td><td>Success Rate</td></tr><tr><td>Skimmed milk with 10% honey.</td><td>The authors state that skimmed milk can be a substitute for blood to produce eggs. An. quadrimaculatus was also fed proteose-peptone, liver concentrate, and casein hydrolysate.</td></tr><tr><td>Mixture of 18 amino ... |
ca2c7b7c1d7a681c553b2c6791d70ad388908ed81c29a98e3fdb3cf22196670a.png | complex | <table><tr><td rowspan="2">Indicator <sup>a,b</sup></td><td colspan="2">Overall Diet</td><td colspan="5">Quintiles of the Contribution of Ultra-Processed Foods to Total Energy Intake</td><td colspan="2">Standardized Regression Coefficient</td></tr><tr><td><i>Mean</i></td><td><i>SE</i></td><td>Q1</td><td>Q2</td><td>Q3</... | <table><tr><td rowspan="2">Indicator a,b</td><td colspan="2">Overall Diet</td><td colspan="5">Quintiles of the Contribution of Ultra-Processed Foods to Total Energy Intake</td><td colspan="2">Standardized Regression Coefficient</td></tr><tr><td>Mean</td><td>SE</td><td>Q1</td><td>Q2</td><td>Q3</td><td>Q4</td><td>Q5</td>... | <table><tr><td rowspan="2">Indicator a,b</td><td colspan="2">Overall Diet</td><td colspan="5">Quintiles of the Contribution of Ultra-Processed Foods to Total Energy Intake</td><td colspan="2">Standardized Regression Coefficient</td></tr><tr><td>Mean</td><td>SE</td><td>Q1</td><td>Q2</td><td>Q3</td><td>Q4</td><td>Q5</td>... |
8f7ba5c6aed4718cdef53b8e5938335ef01f46d7370c6416af8bebf04950da98.png | simple | <table><tr><td>Type of services</td><td>Quantitative indicators (Survey of female workers)</td><td>Qualitative indicators</td></tr><tr><td>Hotline</td><td>• Frequency of services• Ranking frequent topic of call• Number of calls over time• % of women ever heard about the services• % of wome... | <table><tr><td>Type of services</td><td>Quantitative indicators (Survey of female workers)</td><td>Qualitative indicators</td></tr><tr><td>Hotline</td><td>• Frequency of services• Ranking frequent topic of call• Number of calls over time• % of women ever heard about the services• % of women ever used services• Ranking ... | <table><tr><td>Map of health care services providers</td><td>• Number of health services provided surveyed and presented in map• % of women ever received map• % of women ever used map to find health care providers• Ranking about quality/importance of services</td><td>• In-depth information about relevance, quality and ... |
a633f28d8d4ae3aff2fb3dda73539d0100e20dfda44b8bdcad4c9c28c422e27b.png | simple | <table><tr><td>Author (Year)</td><td>Number of patients with seminoma</td><td>Residual disease</td><td>Necrosis/scar</td></tr><tr><td>Chong <i>et al</i> (1986) [8]</td><td>5</td><td>1 (20%)</td><td>4 (80%)</td></tr><tr><td>Greist <i>et al</i> (1984) [7]<sup>a</sup></td><td>1</td><td>NA</td><td>NA</td></tr><tr><td>Ng (1... | <table><tr><td>Author (Year)</td><td>Number of patients with seminoma</td><td>Residual disease</td><td>Necrosis/scar</td></tr><tr><td>Chong et al (1986) [8]</td><td>5</td><td>1 (20%)</td><td>4 (80%)</td></tr><tr><td>Greist et al (1984) [7]a</td><td>1</td><td>NA</td><td>NA</td></tr></table> | <table><tr><td>Ng (1997) [12]</td><td>1b</td><td>0</td><td>1b</td></tr><tr><td>Geldart et al (2002) [13]</td><td>18</td><td>3 (16.7%)</td><td>15 (83.3%)</td></tr><tr><td>Ramani et al (2008) [16]</td><td>13</td><td>0</td><td>13 (100%)</td></tr><tr><td>Miller et al (2012) [17]c</td><td>6</td><td>4</td><td>2 (33.3%)</td><... |
33964d8871a959e4b92b53a685bd835d3dfc995209f3145fd2327324f9038846.png | simple | <table><tr><td></td><td>All tumors</td><td>TC</td><td>AC</td><td>LCNEC</td></tr><tr><td>Clinical status at last f/u</td><td></td><td></td><td></td><td></td></tr><tr><td><i>Alive without recurrence</i></td><td>35</td><td>30</td><td>5</td><td>0</td></tr><tr><td><i>Alive with recurrence</i></td><td>2</td><td>0</td><td>1</... | <table><tr><td></td><td>All tumors</td><td>TC</td><td>AC</td><td>LCNEC</td></tr><tr><td>Clinical statu</td><td></td><td></td><td></td><td></td></tr></table> | <table><tr><td>s at last f/u</td><td></td><td></td><td></td><td></td></tr><tr><td>Alive without recurrence</td><td>35</td><td>30</td><td>5</td><td>0</td></tr><tr><td>Alive with recurrence</td><td>2</td><td>0</td><td>1</td><td>1</td></tr><tr><td>Alive, unknown</td><td>7</td><td>6</td><td>0</td><td>1</td></tr><tr><td>Die... |
e15ffeca0c73ea41a6819de0bc0872ef8fb5520175dad31e1a61731188763293.png | complex | <table><tr><td>CO initial liquid conc. (mM) (headspace, atm)</td><td><i>t</i><sub>max</sub> (d)<sup>*</sup></td><td>CO specific activity (mmol CO/g VSS.d)</td><td>Relative CO conversion rate (%)<sup>§</sup></td><td>CH<sub>4</sub> specific activity (mmol CO/g VSS.d)</td><td>Relative CH<sub>4</sub> conversion rate (... | <table><tr><td>CO initial liquid conc. (mM) (headspace, atm)</td><td>tmax (d)*</td><td>CO specific activity (mmol CO/g VSS.d)</td><td>Relative CO conversion rate (%)§</td><td>CH4 specific activity (mmol CO/g VSS.d)</td><td>Relative CH4 conversion rate (%)§</td><td colspan="3">Products formed (% of the stoichiometric yi... | <table><tr><td>0.17 (0.2)</td><td>4</td><td>2.39 ± 0.46</td><td>45 ± 9</td><td>0.01 ± 0.0</td><td>1</td><td>9 ± 0.3</td><td>51 ± 8</td><td>7 ± 0.4</td><td>5.6 ± 2.3</td></tr><tr><td>0.26 (0.3)</td><td>5</td><td>2.14 ± 0.11</td><td>30 ± 2</td><td>0.03 ± 0.01</td><td>6 ± 2</td><td>12 ± 3</td><td>82 ± 4</td><td>17 ± 1</td... |
77b6d15404fb82f729c49358c1f9afb8d314e482f45cd843c60ac62d6285a559.png | simple | <table><tr><td>SEQUENCE</td><td>ENERGY</td><td>SEQUENCE</td><td>ENERGY</td></tr><tr><td>AAA</td><td>-0.65821</td><td>AAAAA</td><td>-2.84828</td></tr><tr><td>AAB</td><td>0.03223</td><td>AAAAB</td><td>-1.58944</td></tr><tr><td>ABA</td><td>-0.65821</td><td>AAABA</td><td>-2.44493</td></tr><tr><td>ABB</td><td>0.03223</td><t... | <table><tr><td>SEQUENCE</td><td>ENERGY</td><td>SEQUENCE</td><td>ENERGY</td></tr><tr><td>AAA</td><td>-0.65821</td><td>AAAAA</td><td>-2.84828</td></tr><tr><td>AAB</td><td>0.03223</td><td>AAAAB</td><td>-1.58944</td></tr><tr><td>ABA</td><td>-0.65821</td><td>AAABA</td><td>-2.44493</td></tr><tr><td>ABB</td><td>0.03223</td><t... | <table><tr><td>ABA</td><td>-1.45098</td><td>ABA</td><td>020</td></tr><tr><td>AABB</td><td>0.06720</td><td>ABABB</td><td>-0.61680</td></tr><tr><td>ABAB</td><td>0.64938</td><td>ABBAB</td><td>-0.00565</td></tr><tr><td>ABBA</td><td>-0.03617</td><td>ABBBA</td><td>-0.39804</td></tr><tr><td>ABBB</td><td>0.00470</td><td>ABBBB<... |
80e4263354c45d8b07bb9c4a313028e0836657d1da8d129cf85ef2123e43277c.png | simple | <table><tr><td>Drug</td><td>Route</td><td>IC<sub>50</sub>(μM)</td><td>Max serum level (μM)</td><td>Elimination half life</td><td>Efficacy</td><td>Mode of action</td></tr><tr><td><i>Aclarubicin</i></td><td>IV</td><td>0.94</td><td>0.34</td><td>13.3 hrs</td><td>-122.30</td><td>Topoisomerase I and II inhibitor</t... | <table><tr><td>Drug</td><td>Route</td><td>IC50(μM)</td><td>Max serum level (μM)</td><td>Elimination half life</td><td>Efficacy</td><td>Mode of action</td></tr><tr><td>Aclarubicin</td><td>IV</td><td>0.94</td><td>0.34</td><td>13.3 hrs</td><td>-122.30</td><td>Topoisomerase I and II inhibitor</td></tr><tr><td>Actinomycin D... | <table><tr><td>Bortezomib</td><td>IV</td><td>0.34</td><td>0.16-0.31</td><td>9-15 hrs</td><td>-77.11</td><td>Proteasome inhibitor;</td></tr><tr><td>Carboquone</td><td>PO/IV</td><td>0.75</td><td>0.62-0.74 (200-240 ng/mL)</td><td>0.5 hrs</td><td>-119.79</td><td>Alkylating agents</td></tr><tr><td>Ciclopirox</td><td>Topical... |
9662066eea85145b8d7cba0dab26a253c37081100d74b68bb2d16fb17e9d28af.png | complex | <table><tr><td rowspan="2">Results</td><td colspan="8">Data Frequency (Hz)</td></tr><tr><td>10</td><td>4</td><td>2</td><td>1</td><td>0.5</td><td>0.33</td><td>0.25</td><td>0.2</td></tr><tr><td>Training instances</td><td>729,097</td><td>364,588</td><td>184,297</td><td>98,301</td><td>50,805</td><td>34,291</td><td>25,527</... | <table><tr><td rowspan="2">Results</td><td>Data Frequency (Hz)</td></tr><tr><td>10</td></tr><tr><td>Training instances</td><td>729,097</td></tr><tr><td>Test instances</td><td>6,561,871</td></tr><tr><td>Overall accuracy (%)</td><td>99.963</td></tr><tr><td>Time (s)</td><td>304.86</td></tr></table> | <table><tr><td colspan="7">Data Frequency (Hz)</td></tr><tr><td>4</td><td>2</td><td>1</td><td>0.5</td><td>0.33</td><td>0.25</td><td>0.2</td></tr><tr><td>364,588</td><td>184,297</td><td>98,301</td><td>50,805</td><td>34,291</td><td>25,527</td><td>20,566</td></tr><tr><td>3,281,290</td><td>1,658,673</td><td>884,709</td><td... |
af5d917e1cc2d04dc87a91f778f1649b49a199c899832d6dea1687c5d1aa965a.png | simple | <table><tr><td>Dataset</td><td>Description</td><td>Updated</td><td>Genes</td><td>Reference</td></tr><tr><td>hg18rpa</td><td>Protein-coding genes on autosomal chromosomes (based on human genome hg18 and RefSeq genes)</td><td>2011</td><td>18,166</td><td>[35]</td></tr><tr><td>HI</td><td>Recombination hotspots intersected ... | <table><tr><td>Dataset</td><td>Description</td><td>Updated</td><td>Genes</td><td>Reference</td></tr><tr><td>hg18rpa</td><td>Protein-coding genes on autosomal chromosomes (based on human genome hg18 and RefSeq genes)</td><td>2011</td><td>18,166</td><td>[35]</td></tr><tr><td>HI</td><td>Recombination hotspots intersected ... | <table><tr><td>AGE</td><td>Genes classified by different evolutionary age</td><td>2011</td><td>16,418</td><td>[17]</td></tr><tr><td>OMIM</td><td>Mendelian disorder associated genes in human</td><td>2012</td><td>2,624</td><td>[39]</td></tr><tr><td>MD</td><td>Mendelian Disease Genes (at least one mutation in the particul... |
c5744d69d5359a6a006f9f069112e0834b5c51c11ef434f226e2c5e2b4358a6a.png | simple | <table><tr><td></td><td>Inoculated andContacts vs.Controls</td><td>Inoculated vs.Contacts</td><td>Carriers vs.Non-Carriers</td></tr><tr><td>SAA</td><td><0.0001***</td><td>0.61</td><td>0.49</td></tr><tr><td>IFN</td><td><0.0001***</td><td>0.43</td><td>0.27</td></tr><tr><td>Haptoglobin</td><td><0.0001***</td><td>... | <table><tr><td></td><td>Inoculated andContacts vs.Controls</td><td>Inoculated vs.Contacts</td><td>Carriers vs.Non-Carriers</td></tr><tr><td>SAA</td><td><0.0001***</td><td>0.61</td><td>0.49</td></tr></table> | <table><tr><td>IFN</td><td><0.0001***</td><td>0.43</td><td>0.27</td></tr><tr><td>Haptoglobin</td><td><0.0001***</td><td>0.04*</td><td>0.015*</td></tr></table> |
dc43f74e41a2b584143d5c9f8a82e06c50f0893698dcaf2e0e58e4fe1ce4971b.png | simple | <table><tr><td>Gene name</td><td>Sequence (5’–3’)</td></tr><tr><td>β<i>-actin</i></td><td>Sense: TCTTGGGTATGGAGTCCTGAntisense: TAGAAGCATTTGCGGTGG</td></tr><tr><td><i>FGA</i></td><td>Sense: GCAGAACAGCATCCAGGAGCAGGAntisense: TCCACCTGGTAATCAAAACTTCTAGCAC</td></tr><tr><td><i>CA2</i></td><td>Sense: CA... | <table><tr><td>Gene name</td><td>Sequence (5’–3’)</td></tr><tr><td>β-actin</td><td>Sense: TCTTGGGTATGGAGTCCTGAntisense: TAGAAGCATTTGCGGTGG</td></tr><tr><td>FGA</td><td>Sense: GCAGAACAGCATCCAGGAGCAGGAntisense: TCCACCTGGTAATCAAAACTTCTAGCAC</td></tr><tr><td>CA2</td><td>Sense: CACTGGCACGAGCACTTCAntisense: ACTTCACGCCATCCACA... | <table><tr><td>Apo A-I</td><td>Sense: TCCGCTTCGTAGAGAGATGTGAntisense: TCAGCGTGTCCAGGTTGTC</td></tr></table> |
85da63a3f5d330f08ebaa9207ea49942f33d4f208821e52c40f61dd0d9a324a7.png | complex | <table><tr><td></td><td colspan="3">Independently (N = 372)</td><td colspan="3">Long-term care facility (N = 107)</td></tr><tr><td></td><td>N</td><td>HR (95%CI)</td><td><i>P-</i>value</td><td>N</td><td>HR (95%CI)</td><td><i>P-</i>value</td></tr><tr><td><i>Socio-demographic factors</i></td><td></td><td></td><td></td><td... | <table><tr><td></td></tr><tr><td></td></tr><tr><td>Socio-demographic factors</td></tr><tr><td>Female</td></tr><tr><td>Low income</td></tr><tr><td>Primary school only</td></tr><tr><td>Smoking (current)</td></tr><tr><td>Body Mass Index ≥27</td></tr><tr><td>Functioning</td></tr><tr><td>Severe cognitive impairment(MMSE < 1... | <table><tr><td colspan="3">Independently (N = 372)</td><td colspan="3">Long-term care facility (N = 107)</td></tr><tr><td>N</td><td>HR (95%CI)</td><td>P-value</td><td>N</td><td>HR (95%CI)</td><td>P-value</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>242</td><td>1.4 (0.9, 2.3)</td><td>0... |
db3d5648e5afaccf5b5db9636a913435120db766ff7a9f2f65ed562a47d75630.png | complex | <table><tr><td rowspan="3">Variable</td><td colspan="3">Unadjusted</td><td colspan="3">Adjusted</td></tr><tr><td>OR</td><td>95%CI</td><td>p</td><td>OR</td><td>95%CI</td><td>p</td></tr><tr><td colspan="7">Level 1<sup>a</sup> – Demographic characteristics</td></tr><tr><td>Education level</td><td> </td><td> </td><td... | <table><tr><td rowspan="3">Variable</td><td colspan="3">Unadjusted</td><td colspan="3">Adjusted</td></tr><tr><td>OR</td><td>95%CI</td><td>p</td><td>OR</td><td>95%CI</td><td>p</td></tr><tr><td colspan="6"></td></tr><tr><td colspan="7">Level 1a – Demographic characteristics</td></tr><tr><td>Education level</td><td></td><... | <table><tr><td>No</td><td>1.00</td><td></td><td></td><td>0</td><td></td><td></td></tr><tr><td>Yes</td><td>10.68</td><td>6.46–17.66</td><td></td><td>9.70</td><td>5.46–17.24</td><td></td></tr></table> |
f0a8d8e19ed7a8193062690428363f9510370c519c1e63c70c4d609992aa54f1.png | simple | <table><tr><td>Setting</td><td>Number of hours</td><td>Number of days</td><td>Time period</td></tr><tr><td>999</td><td>170</td><td>41</td><td>Nov 2008 – Jul 2010</td></tr><tr><td>SPA</td><td>172</td><td>33</td><td>Oct 2009 – July 2010</td></tr><tr><td>OOH</td><td>149</td><td>27</td><td>Sept 2009 – Aug... | <table><tr><td>Setting</td><td>Number of hours</td><td>Number of days</td><td>Time period</td></tr><tr><td>999</td><td>170</td><td>41</td><td>Nov 2008 – Jul 2010</td></tr></table> | <table><tr><td>SPA</td><td>172</td><td>33</td><td>Oct 2009 – July 2010</td></tr><tr><td>OOH</td><td>149</td><td>27</td><td>Sept 2009 – Aug 2010</td></tr><tr><td>Total</td><td>491</td><td>101</td><td>Nov 2008 – Aug 2010</td></tr></table> |
303c5e08da5f2914b64f837abec4818034c28abec1a4281141d4177c55c33643.png | simple | <table><tr><td></td><td>Control</td><td>Cold</td><td>Fold increase</td></tr><tr><td><i>Col-0</i></td><td>2.1 , 0.7</td><td>6.0 , 1.1</td><td>2.9</td></tr><tr><td><i>dgk1-1</i></td><td>2.2 , 0.5</td><td>5.1 , 0.4</td><td>2.3</td></tr><tr><td><i>dgk2-1</i></td><td>2.2 , 0.6</td><td>6.7 , 1.7</td><td>3.1</td></tr><tr><td>... | <table><tr><td></td><td>Control</td><td>Cold</td><td>Fold increase</td></tr><tr><td>Col-0</td><td>2.1 , 0.7</td><td>6.0 , 1.1</td><td>2.9</td></tr><tr><td>dgk1-1</td><td>2.2 , 0.5</td><td>5.1 , 0.4</td><td>2.3</td></tr><tr><td>dgk2-1</td><td>2.2 , 0.6</td><td>6.7 , 1.7</td><td>3.1</td></tr><tr><td>dgk2-2</td><td>1.9 , ... | <table><tr><td></td><td>Control</td><td>Cold</td><td>Fold increase</td></tr><tr><td>dgk7-2</td><td>2.3 , 0.5</td><td>10.3 , 1.0**</td><td>4.5</td></tr><tr><td>dgk7-3</td><td>1.8 , 0.2</td><td>8.7 , 0.5</td><td>4.9</td></tr></table> |
af594ade52b03681f8655cd296edd04e1f20e2b833e1d98e71174d8e77c43b5d.png | simple | <table><tr><td>Substance</td><td>Mechanism</td><td>Cancer Type</td><td>Reference</td></tr><tr><td>β-asarone</td><td>p53/Bcl-2/Bclin-1 and p53/AMPK/mTOR pathways</td><td>Glioma cell line (U251)</td><td>[161]</td></tr><tr><td>Walsuronoid B</td><td>ROS-formation and activation of p53/PI3K/Akt/mTOR signaling pathway</... | <table><tr><td>Substance</td><td>Mechanism</td><td>Cancer Type</td><td>Reference</td></tr><tr><td>β-asarone</td><td>p53/Bcl-2/Bclin-1 and p53/AMPK/mTOR pathways</td><td>Glioma cell line (U251)</td><td>[161]</td></tr></table> | <table><tr><td>Substance</td><td>Mechanism</td><td>Cancer Type</td><td>Reference</td></tr><tr><td>Walsuronoid B</td><td>ROS-formation and activation of p53/PI3K/Akt/mTOR signaling pathway</td><td>Liver cancer (HepG2 and Bel-7402)</td><td>[166]</td></tr><tr><td>Sulforaphane</td><td>Reduction of phosphorylation of Akt an... |
cdc37017844a9236fd79462865831700c28387074e74974453e93c48538ad992.png | complex | <table><tr><td></td><td colspan="6">Practice (n=number of participating GPs at commencement)</td></tr><tr><td>Organisational Characteristics</td><td>Eastvale (n = 5)</td><td>Gibson (n = 1)</td><td>Frank (n = 4)</td><td>Southville (n = 7)</td><td>Coopers (n = 7)</td><td>West Sanders (n = 9)</td></tr><tr><td>Funding Stru... | <table><tr><td></td><td colspan="3">Practice (n=number of participating GPs at commencement)</td></tr><tr><td>Organisational Characteristics</td><td>Eastvale (n = 5)</td><td>Gibson (n = 1)</td><td>Frank (n = 4)</td></tr><tr><td>Funding Structure</td><td></td><td></td><td></td></tr><tr><td>Privately owned primary care s... | <table><tr><td colspan="3">Practice (n=number of participating GPs at commencement)</td></tr><tr><td>Southville (n = 7)</td><td>Coopers (n = 7)</td><td>West Sanders (n = 9)</td></tr><tr><td></td><td></td><td></td></tr><tr><td>Y</td><td></td><td></td></tr><tr><td></td><td></td><td>Y</td></tr><tr><td></td><td>Y</td><td><... |
0ba763416376590f4ed8150b5ae116d605ed1a7ba2602f48e5dfd6f105bb6cc7.png | complex | <table><tr><td>Variables</td><td>Adjusted odds ratio</td><td>95% confidence interval</td><td><i>p</i>-value</td></tr><tr><td>Therapeutic Self-Care</td><td>0.74</td><td>0.56, 0.96</td><td>0.03</td></tr><tr><td>Over age 75</td><td>1.01</td><td>0.77, 1.34</td><td>0.93</td></tr><tr><td>Female</td><td>0.77</td><td>0.63, 0.9... | <table><tr><td>Variables</td><td>Adjusted odds ratio</td><td>95% confidence interval</td><td>p-value</td></tr><tr><td>Therapeutic Self-Care</td><td>0.74</td><td>0.56, 0.96</td><td>0.03</td></tr></table> | <table><tr><td>Over age 75</td><td>1.01</td><td>0.77, 1.34</td><td>0.93</td></tr><tr><td>Female</td><td>0.77</td><td>0.63, 0.96</td><td>0.02</td></tr><tr><td>Polypharmacy</td><td>1.11</td><td>0.87, 1.44</td><td>0.40</td></tr><tr><td>Polypharmacy*Therapeutic Self-Care</td><td>1.48</td><td>1.10, 2.02</td><td>0.01</td></t... |
c7b4748972613a4524969d60916dfac6f1cc2b5a840cf52bbe887cd282612112.png | simple | <table><tr><td>Methods</td><td>EdgeC ount</td><td>TP</td><td>FP</td><td>TN</td><td>FN</td><td>FP to TP</td><td>TN to FN</td><td>AURO C</td><td>AUPR</td></tr><tr><td>Gold</td><td>2194</td><td>2194</td><td>0</td><td>400396</td><td>0</td><td>0</td><td>0</td><td>1</td><td>1</td></tr><tr><td>ALL</td><td>5440</td><td>94</td>... | <table><tr><td>Methods</td><td>EdgeC ount</td><td>TP</td><td>FP</td><td>TN</td><td>FN</td><td>FP to TP</td><td>TN to FN</td><td>AURO C</td><td>AUPR</td></tr><tr><td>Gold</td><td>2194</td><td>2194</td><td>0</td><td>400396</td><td>0</td><td>0</td><td>0</td><td>1</td><td>1</td></tr><tr><td>ALL</td><td>5440</td><td>94</td>... | <table><tr><td>Methods</td><td>EdgeC ount</td><td>TP</td><td>FP</td><td>TN</td><td>FN</td><td>FP to TP</td><td>TN to FN</td><td>AURO C</td><td>AUPR</td></tr><tr><td>CMSBE</td><td>735</td><td>20</td><td>715</td><td>399681</td><td>2174</td><td>653</td><td>2750</td><td>0.6181</td><td>0.2333</td></tr><tr><td>K-means</td><t... |
92b293669f254b0e6cf693fa6ced8d278b2ccbe0e91dfe767a0d684446bb5d15.png | simple | <table><tr><td>microRNA</td><td><i>p</i>-value</td><td>Fold change (NB vs CB)</td></tr><tr><td>hsa-miR-222</td><td>0.001</td><td>2.24</td></tr><tr><td>hsa-miR-1292</td><td>0.020</td><td>1.27</td></tr><tr><td>hsa-miR-23a-star</td><td>0.022</td><td>1.27</td></tr><tr><td>hsa-miR-140-5p</td><td>0.009</td><td>1.21</td></tr>... | <table><tr><td>microRNA</td><td>p-value</td><td>Fold change (NB vs CB)</td></tr><tr><td>hsa-miR-222</td><td>0.001</td><td>2.24</td></tr><tr><td>hsa-miR-1292</td><td>0.020</td><td>1.27</td></tr><tr><td>hsa-miR-23a-star</td><td>0.022</td><td>1.27</td></tr><tr><td>hsa-miR-140-5p</td><td>0.009</td><td>1.21</td></tr><tr><td... | <table><tr><td>microRNA</td><td>p-value</td><td>Fold change (NB vs CB)</td></tr><tr><td>hsa-miR-27b-star</td><td>0.038</td><td>1.11</td></tr><tr><td>hsa-miR-215</td><td>0.020</td><td>1.10</td></tr><tr><td>hsa-miR-129-3p</td><td>0.029</td><td>1.10</td></tr><tr><td>hsa-miR-549</td><td>0.011</td><td>1.09</td></tr><tr><td>... |
055ccb5a7a235eaf1e58efe09051ede3bc726a205ff864c57b329faa966975a4.png | complex | <table><tr><td rowspan="3"></td><td colspan="2">Whole SAMPLE</td><td colspan="2">8 year–old group</td><td colspan="2">9 year–old group</td><td colspan="2">10 year–old group</td><td colspan="2">11–12 year–old group</td></tr><tr><td rowspan="2">Prevalencen. (%)</td><td>M</td><td rowspan="2">... | <table><tr><td rowspan="3"></td><td colspan="2">Whole SAMPLE</td><td colspan="2">8 year–old group</td><td colspan="2">9 year–old group</td><td colspan="2">10 year–old group</td><td colspan="2">11–12 year–old group</td></tr><tr><td rowspan="2">Prevalencen. (%)</td><td>M</td><td rowspan="2">Prevalencen. (%)</td><td>M</td... | <table><tr><td rowspan="3"></td><td colspan="2">Whole SAMPLE</td><td colspan="2">8 year–old group</td><td colspan="2">9 year–old group</td><td colspan="2">10 year–old group</td><td colspan="2">11–12 year–old group</td></tr><tr><td rowspan="2">Prevalencen. (%)</td><td>M</td><td rowspan="2">Prevalencen. (%)</td><td>M</td... |
ab68ab796a6f2b9ee646ceb77230303c692f08ce8eb564aad2bc04fbe3beab25.png | complex | <table><tr><td></td><td></td><td></td><td colspan="2">Fold change</td></tr><tr><td>SAGE tag</td><td>RefSeq accession</td><td>Gene ID</td><td>Caudal/rostral (SAGE)</td><td>Caudal/rostral (RT-qPCR)</td></tr><tr><td>gttgttcttccagtcgg</td><td>NM_016916</td><td>bladder cancer associated protein homolog (human), <i>Blcap</i>... | <table><tr><td></td><td></td><td></td><td colspan="2">Fold change</td></tr><tr><td>SAGE tag</td><td>RefSeq accession</td><td>Gene ID</td><td>Caudal/rostral (SAGE)</td><td>Caudal/rostral (RT-qPCR)</td></tr><tr><td>gttgttcttccagtcgg</td><td>NM_016916</td><td>bladder cancer associated protein homolog (human), Blcap</td><t... | <table><tr><td>gtcatagctgttctgtg</td><td>BC025816</td><td>EST sequence BC025816</td><td>Cs</td><td>1.31 (NS)</td></tr><tr><td>aagcttgacatttggaa</td><td>NM_026187</td><td>ankyrin repeat and zinc finger domain containing 1, Ankzf1</td><td>Rs</td><td>1.17† (NS)</td></tr><tr><td>gatacttggaatgacta</td><td>NM_007393</td><td>... |
c171becdf65cda83387bead85430db6ab253713080bfa07d90aebd831ca73d44.png | simple | <table><tr><td></td><td>Prescription</td><td>Market</td><td>Patient</td><td>Physician</td></tr><tr><td>TotalVPC (in %)</td><td>42.3[39.0; 45.6]</td><td>50.3[46.4; 54.2]</td><td>4.9[4.5; 5.3]</td><td>2.1[1.9; 2.3]</td></tr><tr><td>Residualvariance (in %)</td><td>34.8[34.7 34.9]</td><td>38.7[33.2; 45.3]</td><td>2.6[2.6; ... | <table><tr><td></td><td>Prescription</td><td>Market</td><td>Patient</td><td>Physician</td></tr><tr><td>TotalVPC (in %)</td><td>42.3[39.0; 45.6]</td><td>50.3[46.4; 54.2]</td><td>4.9[4.5; 5.3]</td><td>2.1[1.9; 2.3]</td></tr></table> | <table><tr><td></td><td>Prescription</td><td>Market</td><td>Patient</td><td>Physician</td></tr><tr><td>Residualvariance (in %)</td><td>34.8[34.7 34.9]</td><td>38.7[33.2; 45.3]</td><td>2.6[2.6; 2.7]</td><td>1.2[1.2; 1.3]</td></tr></table> |
c7da9f8b7b1cddff4b50e0e52c592f5b399b3b7c56b12b3a1123eee9b548a769.png | complex | <table><tr><td></td><td>OHIP-14 Subscales Characteristics</td><td colspan="3">DMFT category</td><td rowspan="2">Statistics Spearman Ranks (rs) correlation<sup>a</sup></td></tr><tr><td></td><td></td><td>Acceptable DMFT <3 <i>N</i> = 341% = 48.7Mean subscale (S.D)</td><td>Average DMFT 4–10<i>N</i> = 220% = 31.4M... | <table><tr><td></td><td>OHIP-14 Subscales Characteristics</td><td colspan="3">DMFT category</td><td rowspan="2">Statistics Spearman Ranks (rs) correlationa</td></tr><tr><td></td><td></td><td>Acceptable DMFT <3 N = 341% = 48.7Mean subscale (S.D)</td><td>Average DMFT 4–10N = 220% = 31.4Mean subscale (S.D)</td><td>Poor DM... | <table><tr><td></td><td>OHIP-14 Subscales Characteristics</td><td colspan="3">DMFT category</td><td rowspan="2">Statistics Spearman Ranks (rs) correlationa</td></tr><tr><td></td><td></td><td>Acceptable DMFT <3 N = 341% = 48.7Mean subscale (S.D)</td><td>Average DMFT 4–10N = 220% = 31.4Mean subscale (S.D)</td><td>Poor DM... |
c616e366ed42e4a06e17c9739307229e9975d8fd4b2c2a0b4f9cd64c7db81c4f.png | complex | <table><tr><td rowspan="2">Target gene</td><td rowspan="2">Primer name</td><td rowspan="2">Nucleotide sequence (5'–3')</td><td rowspan="2">Product size (bp)</td><td colspan="4">PCR profile (°C/s)</td><td rowspan="2">Reference</td></tr><tr><td>Denaturation</td><td>Annealing</td><td>Extension</td><td>Cycles</t... | <table><tr><td rowspan="2">Target gene</td><td rowspan="2">Primer name</td><td rowspan="2">Nucleotide sequence (5'–3')</td><td rowspan="2">Product size (bp)</td><td colspan="4">PCR profile (°C/s)</td><td rowspan="2">Reference</td></tr><tr><td>Denaturation</td><td>Annealing</td><td>Extension</td><td>Cycles</td></tr><tr>... | <table><tr><td rowspan="2">Target gene</td><td rowspan="2">Primer name</td><td rowspan="2">Nucleotide sequence (5'–3')</td><td rowspan="2">Product size (bp)</td><td colspan="4">PCR profile (°C/s)</td><td rowspan="2">Reference</td></tr><tr><td>Denaturation</td><td>Annealing</td><td>Extension</td><td>Cycles</td></tr><tr>... |
54cd7c76d1961159af41125213050a81dece91adf034037b8dad95b6948fc358.png | complex | <table><tr><td rowspan="2"> Type</td><td colspan="4">Number of cases</td></tr><tr><td>Detected</td><td>Misreported</td><td>Under-reported</td><td>Total</td></tr><tr><td>Probe</td><td>226</td><td>4</td><td>7</td><td>233</td></tr><tr><td>DoS</td><td>131</td><td>14</td><td>23</td><td>155</td></tr><tr><td>R2L</td><td>77</t... | <table><tr><td rowspan="2">Type</td><td colspan="4">Number of cases</td></tr><tr><td>Detected</td><td>Misreported</td><td>Under-reported</td><td>Total</td></tr></table> | <table><tr><td>Probe</td><td>226</td><td>4</td><td>7</td><td>233</td></tr><tr><td>DoS</td><td>131</td><td>14</td><td>23</td><td>155</td></tr><tr><td>R2L</td><td>77</td><td>12</td><td>12</td><td>89</td></tr><tr><td>U2R</td><td>29</td><td>12</td><td>8</td><td>36</td></tr></table> |
8b5b215135164034de260ca7f42960f2d2f6fc1694bea171a666bb3318affe47.png | complex | <table><tr><td></td><td colspan="6">N (Percentage)</td></tr><tr><td>Characteristic</td><td>Quintile 1</td><td>Quintile 2</td><td>Quintile 3</td><td>Quintile 4</td><td>Quintile 5</td><td>p value</td></tr><tr><td>Median z score</td><td>-6.11</td><td>-3.21</td><td>-0.55</td><td>2.58</td><td>7.67</td><td></td></tr><tr><td>... | <table><tr><td></td><td colspan="6">N (Percentage)</td></tr><tr><td>Characteristic</td><td>Quintile 1</td><td>Quintile 2</td><td>Quintile 3</td><td>Quintile 4</td><td>Quintile 5</td><td>p value</td></tr><tr><td>Median z score</td><td>-6.11</td><td>-3.21</td><td>-0.55</td><td>2.58</td><td>7.67</td><td></td></tr><tr><td>... | <table><tr><td></td><td colspan="6">N (Percentage)</td></tr><tr><td>Characteristic</td><td>Quintile 1</td><td>Quintile 2</td><td>Quintile 3</td><td>Quintile 4</td><td>Quintile 5</td><td>p value</td></tr><tr><td>$20 K–$34 K</td><td>1079 (29)</td><td>1064 (28)</td><td>1001 (27)</td><td>853 (23)</td><td>514 (14)</td><td><... |
b5ba89bcc34b91142c70886954135d437d76dc0ec48eac8c2728f4c201481c93.png | complex | <table><tr><td>Feature of presenting complaint</td><td>Study participants (<i>n</i> = 30)</td></tr><tr><td colspan="2">Trauma (%)</td></tr><tr><td> Yes</td><td>16 (53.3)</td></tr><tr><td> No</td><td>14 (46.7)</td></tr><tr><td colspan="2">Weight-bearing (%)</td></tr><tr><td> Yes</td><td>17 (56.7)</td></tr><tr><td> No</t... | <table><tr><td>Feature of presenting complaint</td><td>Study participants (n = 30)</td></tr><tr><td colspan="2">Trauma (%)</td></tr><tr><td>Yes</td><td>16 (53.3)</td></tr><tr><td>No</td><td>14 (46.7)</td></tr><tr><td colspan="2">Weight-bearing (%)</td></tr><tr><td>Yes</td><td>17 (56.7)</td></tr><tr><td>No</td><td>13 (4... | <table><tr><td>Other</td><td>4 (13.3)</td></tr><tr><td>Unknown diagnosis</td><td>1 (3.3)</td></tr></table> |
722886f8e661ceb31fd6dc823fc9e3ac642533050022459dcf5ab8cc21f9bade.png | complex | <table><tr><td>Evaluation</td><td colspan="2">Any Difference(Mack Skillings Test)</td><td colspan="2">Paired Comparisons*(Signed Rank Test)</td></tr><tr><td></td><td>Raw P Value</td><td>Adjusted P Value</td><td>P Value of Cycle 1 Comparisons</td><td>P Value of Cycle 2 Comparisons</td></tr><tr><td>CD4+</td><td>0.0203</t... | <table><tr><td>Evaluation</td><td>Any Difference(Mack Skillings Test)</td></tr><tr><td></td><td>Raw P Value</td></tr><tr><td>CD4+</td><td>0.0203</td></tr><tr><td>CD8+</td><td>0.0207</td></tr><tr><td>CD56+</td><td>-</td></tr><tr><td>CD16+/CD56+</td><td>-</td></tr><tr><td>CD25+</td><td>0.3192</td></tr><tr><td>CD27+</td><... | <table><tr><td>Any Difference(Mack Skillings Test)</td><td colspan="2">Paired Comparisons*(Signed Rank Test)</td></tr><tr><td>Adjusted P Value</td><td>P Value of Cycle 1 Comparisons</td><td>P Value of Cycle 2 Comparisons</td></tr><tr><td>0.1827</td><td>-</td><td>-</td></tr><tr><td>0.1827</td><td>-</td><td>-</td></tr><t... |
e647741d2ab0d600b40d9dece1725ef0bbb4b98ae582fd3aaf5c924897e8ee02.png | simple | <table><tr><td>Month(s)</td><td>NT-proBNP (fmol/ml)</td><td>IL-6 (pg/ml)</td><td>Adiponectin (ng/ml)</td></tr><tr><td>1</td><td>172.79±4.32</td><td>13.24±1.25</td><td>15.19±0.86</td></tr><tr><td>3</td><td>292.43±7.59**</td><td>116.09±8.78**</td><td>12.54±1.61*</td></tr><tr><td>6</td><td>33... | <table><tr><td>Month(s)</td><td>NT-proBNP (fmol/ml)</td><td>IL-6 (pg/ml)</td><td>Adiponectin (ng/ml)</td></tr></table> | <table><tr><td>1</td><td>172.79±4.32</td><td>13.24±1.25</td><td>15.19±0.86</td></tr><tr><td>3</td><td>292.43±7.59**</td><td>116.09±8.78**</td><td>12.54±1.61*</td></tr><tr><td>6</td><td>339.43±12.59**</td><td>181.29±16.45**</td><td>12.25±0.29*</td></tr><tr><td>9</td><td>348.53±15.85 **</td><td>223.61±12.43**</td><td>11.... |
ef16de2e9d53a92eb91391b9187da534ae8ba1aa7adc374287f4d168bec8cfc3.png | simple | <table><tr><td></td><td>p-value </td><td>Pearson correlations </td></tr><tr><td>Infant age (month) </td><td>0.002 </td><td>-0.270 </td></tr><tr><td>Height at birth (cm) </td><td>0.010 </td><td>0.237 </td></tr><tr><td>Weight at birth (kg) </td><td>0.940 </td><td>-0.007 </td></tr><tr><td>Head circumference at birth (cm) ... | <table><tr><td></td><td>p-value</td><td>Pearson correlations</td></tr><tr><td>Infant age (month)</td><td>0.002</td><td>-0.270</td></tr><tr><td>Height at birth (cm)</td><td>0.010</td><td>0.237</td></tr><tr><td>Weight at birth (kg)</td><td>0.940</td><td>-0.007</td></tr></table> | <table><tr><td></td><td>p-value</td><td>Pearson correlations</td></tr><tr><td>Head circumference at birth (cm)</td><td>0.251</td><td>0.157</td></tr></table> |
a238c1e47a0e25f9efff5e40190d3d4f02711048332b4540fc57b733bc74958e.png | simple | <table><tr><td>Annotation category</td><td>Number of annotations</td></tr><tr><td>Natural antisense lncRNA</td><td>64</td></tr><tr><td>Pseudogene</td><td>75</td></tr><tr><td>Transposable element gene</td><td>10</td></tr><tr><td>Transposase</td><td>46</td></tr><tr><td>miRNA primary transcript</td><td>4</td></tr><tr><td>... | <table><tr><td>Annotation category</td><td>Number of annotations</td></tr><tr><td>Natural antisense lncRNA</td><td>64</td></tr><tr><td>Pseudogene</td><td>75</td></tr></table> | <table><tr><td>Annotation category</td><td>Number of annotations</td></tr><tr><td>Transposable element gene</td><td>10</td></tr><tr><td>Transposase</td><td>46</td></tr><tr><td>miRNA primary transcript</td><td>4</td></tr><tr><td>Hypothetical protein</td><td>5</td></tr><tr><td>Protein</td><td>8</td></tr><tr><td>Other</td... |
1bb2f6f3bd1ddab8a81aa640a92c9a7ac5fec8c10681e292f717f2847d047e4f.png | complex | <table><tr><td>Sharing platform</td><td colspan="2">Current users, <i>n</i> = 200<i>n</i> (%)</td></tr><tr><td>Do not share data</td><td>130</td><td>(65.0%)</td></tr><tr><td>Tracker support software</td><td>70</td><td>(35.0%)</td></tr><tr><td>Strava</td><td>9</td><td>(4.5%)</td></tr><tr><td>Facebook</td><td>7</td><td>(... | <table><tr><td>Sharing platform</td><td colspan="2">Current users, n = 200n (%)</td></tr><tr><td>Do not share data</td><td>130</td><td>(65.0%)</td></tr><tr><td>Tracker support software</td><td>70</td><td>(35.0%)</td></tr><tr><td>Strava</td><td>9</td><td>(4.5%)</td></tr><tr><td>Facebook</td><td>7</td><td>(3.5%)</td></tr... | <table><tr><td>Instagram</td><td>2</td><td>(1.0%)</td></tr><tr><td>In person</td><td>2</td><td>(1.0%)</td></tr><tr><td>Twitter</td><td>1</td><td>(0.5%)</td></tr><tr><td>Other</td><td>3</td><td>(1.5%)</td></tr><tr><td colspan="3">Reasons for sharing on social media</td></tr><tr><td>Do not share data on social media</td>... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.